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Abstract 
The number of people requiring an organ transplant in the United States has 
increased considerably over the past 25 years, but the number of organ donations has 
stagnated; over 8,000 people now die annually while awaiting a transplant or become too 
sick to receive one.  Tissue engineering (TE), the design and production of artificial 
tissues and organs in vitro, has been proposed to alleviate this problem.  Though synthetic 
polymers offer tunable mechanical and biochemical properties, natural biomaterials have 
recently garnered attention in TE for their high degree of biocompatibility and ability to 
direct cell proliferation and constructive tissue remodeling. Yet scaffold processing 
remains challenging and a need for novel treatment and fabrication methods still exists. 
One underexplored method for creating TE scaffolds is treatment with 
supercritical fluids (SCFs).  SCFs are appealing for treating biomaterials because of their 
desirable solvent properties; liquid-like densities and gas-like viscosities allow 
supercritical fluids to wet and penetrate matrices easily without damaging surface tension 
effects.  Supercritical carbon dioxide (scCO2) is of particular interest.  scCO2 is a non-
toxic, non-flammable substance that is relatively inert and can be used to process 
biomaterials at physiologic temperatures and mild pressures.  scCO2 treatment avoids 
organic solvents, does not leave cytotoxic residue, and has already been utilized in 
similar biomedical applications, including sterilization, pasteurization, biomolecule 
extraction, and removal of endotoxins, bioburden, and allergenic proteins.   
vii 
Supercritical CO2 has been used in foaming of synthetic polymer scaffolds, but it 
is almost completely unexplored in treatment of natural biomaterials for TE.  In this 
dissertation, the potential of scCO2 in natural biomaterial TE is extensively explored.  
Two commonly-studied natural TE scaffold biomaterials were examined: a single-
component biomaterial, type I collagen, and a multi-component biomaterial, extracellular 
matrix (ECM) obtained by decellularization of porcine aorta.  Both biomaterials were 
studied at the fundamental and applied level.   
First, the chemical compatibility of collagen and liquid and scCO2 was assessed.  
Compatibility was determined based on changes in four biochemical properties: thermal 
stability, molecular weight, secondary structure, and overall appearance.  For scCO2, no 
significant differences were observed, indicating chemical compatibility.  Liquid CO2 
treatment caused significant denaturing, though it was hypothesized that the apparent 
incompatibility may be a result of treatment conditions rather than total incompatibility. 
After chemical compatibility between collagen and scCO2 was established, scCO2 
was applied to crosslinked collagen films to extract residual glutaraldehyde after 
crosslinking.  After 1 hr of scCO2/ethanol treatment, over 95% of residual glutaraldehyde 
was removed, reducing the concentration below 1 ppm.  Differential scanning 
calorimetry analysis showed a high degree of crosslinking and a denaturation temperature 
of about 63°C both before and after scCO2 treatment.  Tensile testing did reveal a 
significant increase in both stiffness and tensile strength caused by scCO2 treatment, 
likely resulting from dehydration caused by the ethanol additive.  However, this 
dehydration is preventable and less disruptive than heat-based removal of residual 
glutaraldehyde. 
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Decellularized ECM is also commonly used as a TE scaffolds.  Current 
decellularization methods often utilize chemical detergents, which are residually 
cytotoxic and can damage ECM composition and ultrastructure.  scCO2 has been 
proposed as a decellularizing agent, but added ethanol severely dehydrates the matrix.  
The second half of this dissertation explores how scCO2 can decellularize a tissue without 
dehydrating it.  To prevent dehydration, a novel presaturation method was developed 
where scCO2 and water are thoroughly mixed before treatment.  Presaturation with water 
led to mass retention of over 99% in a model hydrogel and over 97% in porcine aorta 
during scCO2 treatment, compared to only 46% and 78%, respectively, when dry (pure) 
scCO2 was used, proving that dehydration during scCO2 treatment is easily prevented. 
Finally, scCO2 was used to decellularize porcine aorta.  Contrary to a previous 
report, scCO2 alone was unable to achieve complete cell removal, even with a polar 
additive.  However, when an SDS pretreatment step was used, the same scCO2 treatment 
completely decellularized porcine aorta as indicated by histology and DNA quantitation.  
Presaturation of scCO2 with water maintained the hydration state of the matrix, better 
maintaining the mechanical properties of the native tissue. 
This dissertation confirms the potential of supercritical CO2 as a processing 
method for naturally-derived biomaterial scaffolds.  Further work can be performed to 
determine the efficacy of CO2 on different scaffold compositions and morphologies as 
well as decellularization of other tissue types.  More complex treatments may also be 
possible, such as simultaneous sterilization and decellularization.  These studies provide 
insight into the mechanisms and applications of scCO2 in TE and offer a springboard for 
impactful discoveries in the future. 
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Chapter 1 Introduction 
 At the end of 2013, over 120,000 individuals in the United States were registered 
on the national organ transplant waiting list.  The size of the waiting list has continually 
increased over the past 25 years, while the number of donations plateaued in the 2000s 
and has slightly declined in the 2010s (see Figure 1.1), with the gap between the waiting 
list and the number of annual donations now exceeding 100,000 people [1]. It follows 
that the number of deaths for those awaiting transplantation, currently about 8,000 per 
year, will continue to increase over time.  These statistics clearly indicate that merely 
relying on human organ donation will be insufficient for meeting the medical needs of 
those requiring organ transplantation, both now and in the future. 
One way to address the organ deficit is the production and use of artificial organs.  
An artificial organ is a manmade construct that can perform the tasks and functions of a 
native organ which has been damaged or excised.  Though the concept of artificial organs 
has existed for over a century [2], widespread clinical use of artificial organs still does 
not exist. One exciting and relatively novel method for creating artificial organs is the 
field of tissue engineering (TE). TE involves culturing healthy cells from a patient (or 
from a stem cell line if autologous cells are unavailable) to create a new tissue in vitro, 
which can then be used as a graft to treat a tissue or organ defect [3].  The TE process is 
shown in pictorial form in Figure 1.2. 
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Figure 1.1 – Trends in organ donation in the United States, 1991-2013 (Approved for 
reuse by the United States Department of Health & Human Services; URL: 
https://optn.transplant.hrsa.gov/the-need-is-real-data/)   
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Figure 1.2 – Tissue Engineering Flowchart – (By HIA (Own work) [CC BY 3.0 
(http://creativecommons.org/licenses/by/3.0)], via Wikimedia Commons) 
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For example, one can consider how the TE process would be utilized for a patient 
with a bone defect.  First, a biopsy is taken from the patient’s healthy bone tissue.  
Healthy cells are isolated from the biopsy and then cultured in vitro until reaching an 
appropriate cell density.  Next, the cultured cells are seeded onto a biocompatible three-
dimensional construct called a TE scaffold along with appropriate growth factors and 
mechanical stimuli to create a tissue-engineered graft.  Finally, the graft is implanted into 
the damaged bone. Once inside the body, the cells continue to proliferate and 
differentiate, populating around the scaffold and eventually forming a new tissue or organ 
to replace the damaged one.  The scaffold is designed to naturally degrade over a set 
timeframe and be replaced by newly-deposited extracellular matrix (ECM). 
TE works well in theory, but a number of challenges have prevented its success 
and widespread clinical use.  The biggest challenge is determining the source and design 
of the scaffold.  An effective scaffold biomaterial must satisfy numerous biological, 
chemical, structural, and mechanical criteria, including [4]. 
- High biocompatibility/low immunogenicity to prevent host immune response 
- Interconnected pore structure that allows cell penetration 
- Appropriate morphology for the specific tissue or application 
- Suitable elastic modulus (stiffness) and flexural rigidity 
- Structural integrity to withstand pressure and mechanical forces 
- Surface chemistry that is not too hydrophilic or hydrophobic 
- Absence of any residual cytotoxic agents 
- Sterility to prevent infection after implantation 
- Bioactive and able to promote constructive remodeling 
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Two main approaches to creating TE scaffolds are possible: (1) producing scaffolds from 
synthetic biomaterials, and (2) using scaffolds derived from natural and/or xenogeneic 
sources.  Though both approaches have merit, natural biomaterials offer two primary 
advantages.  First, using naturally-derived scaffolds can reduce the possibility of bodily 
rejection and adverse immune response sometimes observed with synthetic biomaterials 
[5].  Second, recent research has uncovered the importance of ECM proteins in directing 
the tissue towards vascularization, innervation, and proper function; these outcomes are 
collectively called “constructive remodeling” [6].  During constructive remodeling, ECM 
proteins and their degradation products, including cytokines and chemokines, signal cells 
on when to migrate, proliferate, and differentiate [7].  In fact, the constructive remodeling 
effect of ECM proteins is so great that for some biomaterial and tissue combinations, 
such as collagen for bone tissue and elastin for blood vessels, the primary ECM 
component alone can be enough to promote constructive remodeling [8, 9]. 
 
1.1 Decellularization 
Xenogeneic organs or tissues contain non-autologous (foreign) cells, which must 
be removed prior to seeding the matrix to prevent undesired post-implant immune 
response [10, 11].  The process of removing foreign cellular material from a tissue or 
organ is called decellularization. The objective of any decellularization method is 
twofold: (1) to remove all foreign cellular material, and (2) to preserve the physical, 
mechanical, and biochemical properties of the ECM [12].   
Tissues differ in numerous ways, including variations in cell type, cell density, 
physical density, ECM composition, morphology, and thickness.  Because of these 
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differences, there are numerous, highly-varied decellularization protocols that exist for 
different tissues; sometimes there are even very different approaches for decellularizing 
the same type of tissue [13].  Decellularization is most commonly accomplished by 
contacting xenogeneic tissue with chemical detergents, sometimes in conjunction with 
enzymes [14].  Physical methods, such as sonication and agitation, can be used instead of 
or in tandem with chemical methods to decellularize a tissue [15].  Common 
decellularization methods are discussed in greater detail in Chapter 2. 
There is no universal or perfect decellularization protocol.  If treatment is too 
harsh, the ECM will be damaged, compromising mechanical integrity and bioactive 
properties.  If the treatment is too gentle, not all foreign cells will be removed, 
stimulating unwanted immune response [10].  In fact, it is accepted in the field that no 
decellularization treatment will be able to remove all cellular material from a tissue, and 
no treatment will be able to completely avoid damaging the ECM [13].  Therefore, the 
goal and challenge of creating a decellularization protocol is finding a balance between 
preserving enough of the matrix for it to promote constructive remodeling and removing 
enough foreign cellular matter to prevent an inflammatory immune response.  Both of 
these outcomes are required for the recellularized tissue to develop and function properly; 
therefore, the efficacy of a given decellularization technique must be determined by 
evaluating both criteria. Currently, there are no universally-accepted standards for 
determining the extent of decellularization.  However, Badylak’s group has recently 
proposed standards based on the mass and length of residual DNA fragments and the 
absence of cellular material in stained micrographs [12].  There are no universal criteria 
at all for successful ECM preservation, but mechanical properties, pore size and structure, 
  
7 
 
and ECM protein composition are often evaluated after treatment and compared to the 
properties of the native tissue. 
 
1.2 Supercritical Carbon Dioxide 
 An optimal decellularization technique has not yet been discovered, and 
conventional decellularization techniques have several weaknesses that need to be 
addressed.  Most protocols, especially ones that use chemical detergents, are fairly time-
consuming.  Many treatments last on the order of days [16], while treating denser tissues 
like blood vessels can take multiple weeks [17], and this time does not include post-
decellularization processing steps such as sterilization.  Residual detergents can be 
cytotoxic [10], as can residual crosslinking agents [18].  Detergents also can have 
additional deleterious effects in tissues containing basement membranes, such as bladder 
and skin [19, 20].  Because of these issues, novel decellularizing agents and methods for 
applying them are still being pursued. 
One method of processing biomaterials that has gained interest in recent years is 
supercritical fluids (SCFs).  A substance enters the one-phase SCF state upon exceeding 
both its critical temperature (Tc) and critical pressure (Pc), collectively known as the 
critical point (Tc, Pc).  Supercritical fluids are effective solvents because they have 
desirable transport properties, including minimal surface tension, low viscosity, and high 
diffusivity like gases, but they also have liquid-like density and solvation power that are 
much greater than those of most gases [21]. This combination of properties allows SCFs 
to penetrate through surfaces easily without damaging them because of their lack of 
surface tension.  Upon depressurization, the supercritical fluid outgases and exits the 
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system, avoiding problems with residual cytotoxic components often encountered in 
other methods. 
Supercritical carbon dioxide (scCO2), shown in Figure 1.3 (b), is especially 
promising for biomedical applications. The primary reason is thermodynamic: scCO2 has 
unusually low critical conditions.  Its Tc of 31.1°C allows treatment of biological 
materials at or near physiologic temperature (37°C), and its Pc of 7.4 MPa is mild enough 
to treat biomaterials safely.  Additionally, CO2 is readily available and safe – it is 
relatively inert, non-flammable, non-toxic, and non-mutagenic [21].  Equipment and 
processes utilizing supercritical CO2 have already been demonstrated in pasteurization 
[22-24], extraction of biological compounds [25, 26], production of TE scaffolds from 
synthetic polymers [27-29], and sterilization, the latter being a research thrust in our 
group [30-37]. 
Sterilization is of particular importance in TE to prevent nosocomial (hospital-
acquired) infection during surgery.  Traditional sterilization methods like steam 
autoclaving, ethylene oxide, and gamma irradiation are often unsuitable for biomaterials 
[30, 33].  Supercritical CO2 has been proven effective in the sterilization of decellularized 
porcine dermis and lung ECM [38, 39] and has been identified as an important subject of 
future research in scaffold sterilization [12].  Though not directly investigated in this 
dissertation, the possibility of simultaneous decellularization and sterilization or high-
level disinfection using a single CO2 treatment would be a potential boon for the field. 
Additionally, scCO2 has recently been used to aid in other TE processes, including for 
hydrogel foaming [40] and crosslinking of chitosan aerogels [41].  Furthermore, recent 
improvements in scCO2 processing techniques have eliminated the pore interconnectivity 
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Figure 1.3 – Visual Appearance of Dense-Phase CO2: Photographs of (a) CO2 in vapor-
liquid equilibrium and (b) CO2 in the supercritical state.    
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issues that were once a major hindrance to scCO2 polymer foaming techniques [42].  
However, despite the efficacy of scCO2 in the aforementioned applications, its use in 
treatment of natural TE scaffold biomaterials is very limited.  To the best of our 
knowledge, there has been no fundamental research on the chemical compatibility of 
scCO2 with natural biomaterials, such as collagen, and applied work in the literature is 
very limited.  Decellularization with scCO2 is completely unexplored aside from a single 
publication by Sawada’s group in 2008, where significant matrix dehydration was 
reported and no further reports were published [43]. 
 
1.3 Dissertation Objectives 
The overarching objective of this dissertation is to evaluate the potential of scCO2 
for use in the processing and fabrication of naturally-derived TE scaffolds.  This 
objective was accomplished by using scCO2 to treat a simple natural biomaterial, type I 
collagen, and a more complex natural biomaterial, porcine aorta tissue.  As shown in 
Figure 1.4, a fundamental study and an applied study were performed for each 
biomaterial.  The specific aims of this work are: (1) to determine the fundamental 
compatibility of type I collagen with liquid and supercritical CO2, (2) to extract residual 
glutaraldehyde from crosslinked type I collagen films using scCO2, reducing 
glutaraldehyde concentration below cytotoxic levels, (3) to design and develop a method 
for presaturating scCO2 with water and other volatiles to prevent dehydration of model 
scaffold biomaterials, and (4) to decellularize porcine aorta tissue using a scCO2-based  
treatment process and determine the relative effects of key process parameters on cell 
removal and scaffold properties. 
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Figure 1.4 – Dissertation Flowchart: Supercritical CO2 was used to treat both type I 
collagen and porcine aorta in fundamental and applied studies.  
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Very little work has been done previously on fabrication of TE scaffolds with 
scCO2.  The findings of this dissertation will elucidate fundamentals of how supercritical  
fluids and scaffold biomaterials interact.  This knowledge can be leveraged into 
numerous applications for future clinical and industrial benefit in TE and the fields of 
chemical and biomedical engineering. 
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Chapter 2 Literature Review
 In recent decades, industrial and research interest in supercritical CO2 technology 
has seen a considerable increase in a wide variety of applications, including many in the 
biomedical field [44-46].  In recent years, TE has also seen continual growth and progress 
in research and development [3, 13, 47].  As this dissertation lies at the intersection of 
these two important and expanding areas, this chapter includes discussion of current 
knowledge and critical publications in both scCO2 and TE.  The objective of this chapter 
is to establish where and how this dissertation fits into both fields. 
 
2.1 Supercritical CO2 Technology 
 Prior to covering the most prominent applications of scCO2, some background on 
its unique thermodynamic and chemical properties will be discussed.  This subsection 
will then cover extraction, the primary industrial application of scCO2, with a focus on 
extraction of biological compounds.  It will conclude with discussion of two areas of 
scCO2 technology highly relevant to this dissertation: sterilization and TE applications. 
 
2.1.1 Supercritical CO2 Fundamentals 
 A pressure-temperature phase diagram for a pure substance, such as that of CO2 
shown in Figure 2.1, consists primarily of planar one-phase regions (solid, liquid, and 
vapor) and two-phase curves where thermodynamic equilibrium exists between the two   
14 
phases.  These curves on Figure 2.1 are A, the solid-vapor (sublimation) curve; B, the 
solid-liquid (fusion) curve; and C, the liquid-vapor (vaporization) curve.  There also two 
pressure-temperature coordinate points of interest.  Point D is the triple point, where the 
solid, liquid, and vapor phases exist in three-phase equilibrium.  More importantly for 
this work, point E is the critical point.  As the critical point is approached, the liquid and 
vapor phases approach equal densities and the phase boundary disappears.  Once the 
pressure and temperature of the critical point are exceeded, the substance enters the 
supercritical fluid phase [48].  
 Supercritical fluids have a unique combination of properties: densities on the 
order of liquids but diffusivities and viscosities on the order of gases.  Along with having 
minimal surface tension, these solvent properties allow SCFs to penetrate into pores, 
films, and surface openings without damaging them.  SCFs are green, sustainable 
replacements for organic solvents in many applications, especially in the area of cleaning 
materials and surfaces [49].  CO2 is one of the most commonly used supercritical fluids.  
It is non-toxic, non-flammable, non-mutagenic, relatively inert, odorless, readily 
available, and fairly inexpensive [21].  It also has relatively low critical conditions (Tc = 
31.1C, Pc = 7.4 MPa), making it particularly well-suited for biological applications.  A 
myriad of molecules have some degree of solubility in scCO2, especially small, non-polar 
ones [50].  Solubility of polar compounds is sometimes limited, but can be improved in 
many cases by dissolving a polar additive, such as ethanol, in scCO2, [51]. 
 CO2 in the liquid phase is also of interest.  Liquid CO2 exists at similar, 
sometimes greater densities than scCO2, and is therefore also considered a “dense-phase” 
fluid.  Liquid CO2 can exist at pressures as low as 1 MPa, making it desirable for  
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Figure 2.1 – Carbon Dioxide Phase Diagram: A – Sublimation Curve; B – Fusion Curve; 
C – Vaporization Curve; D – Triple Point; E – Critical Point; F – Critical Point Drying  
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applications where the higher temperatures and pressures of supercritical CO2 are 
detrimental, either physically to the specimen or economically because of the higher 
equipment cost [52, 53]. 
One important application of liquid CO2 is critical point drying (CPD), a process 
commonly used in TE [54] and other applications, such as electronics processing [55], 
aerogel formation [56], and scanning electron microscopy [57].  The primary advantage 
of CPD over conventional evaporative drying is that CPD avoids passing through the 
vaporization curve of the phase diagram; circumventing the two-phase region is desirable 
for delicate materials that can be damaged by the surface tension that exists at vapor-
liquid phase boundaries [58].  As shown on line F in Figure 2.1, CPD initiates when a 
liquid solvent, such as ethanol, is removed from a substrate by dissolving it in a second 
benign solvent, typically liquid CO2.  The mixture is then heated and/or pressurized until 
CO2 undergoes a phase transition from the liquid state to the supercritical state.  Finally, 
the pressure is reduced below the critical pressure, allowing the supercritical CO2 to enter 
the gaseous state without undergoing the vapor-liquid phase transition.  The gaseous CO2 
is removed from the system by depressurizing to ambient conditions. 
 Dense-phase CO2 has been utilized in a wide variety of applications, including 
reaction engineering [59], catalysis [60], polymerization [61], chromatography [62], 
particle synthesis [63], thin film synthesis [64], jet cutting [65], textile dyeing [66], and as 
a heat transfer fluid [67].  However, this section will focus on the three realms of CO2 
technology most relevant to this dissertation, which include extraction, sterilization, and 
tissue engineering. 
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2.1.2 Extraction  
Extraction, the process of separating one component from another using a solvent, 
is one of the most widespread applications of supercritical CO2 [21].  One of the oldest 
and best-known SCF extraction process is the decaffeination of coffee [68], which has 
more recently been extended to tea and spent coffee grounds [69, 70].  CO2-based 
extraction has some inorganic applications, such as removal of metal ions from water and 
other materials [71, 72], but the main focus of supercritical extraction is on biological 
molecules.  The extraction of oils, lipids, and organic solvents are of particular interest to 
TE applications. 
Supercritical CO2 extraction of animal and plant oils for supplemental and 
medicinal use has gained considerable attention in recent years.  For example, Ferdosh et 
al. used scCO2 and an ethanol additive to extract and fractionate fish oil, which contains 
healthy omega-3 fatty acids.  The fish oil was extracted from undesired and/or inedible 
tuna parts in a 2 hr process, though 3 days of pretreatment freeze-drying were required 
[73].  CO2 extraction of plant oils has been studied extensively, as well.   Plant oils 
containing fatty acids, one of the two subgroups of lipids, have been traditionally 
extracted using either a mechanical press or organic solvents, such as hexane or 
petroleum ether [74].  However, scCO2 has gained popularity in this field because it 
offers higher yields than a mechanical press without the environmental and safety hazards 
of organic solvents [75].  Some materials are extracted from plant by-products, such as 
lycopene from tomato peels [76], but most oils are extracted from seeds. Some types of 
plant oils successfully extracted with supercritical CO2 include tea seed [75], sunflower 
seed [77], and sesame seed [78], among many others. 
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A key subset of fatty acid-containing oils is those containing conjugated linolenic 
acids, which may help prevent atherosclerosis and fight some types of cancer [79].  Özkal 
et al. extracted flaxseed oil, an abundant source of α-linolenic acid, in 30-60 minutes of 
scCO2 treatment with yields of about 0.3 g/seed [80].  scCO2 extraction of G. 
Pentaphyllum (a Chinese herb) seeds for 160 min yielded an oil containing over 88% 
conjugated linolenic acids, which inhibited the viability of both leukemic and colon 
cancer cells by about 80% [81].  Another notable subset of fatty acids is phytosterols, 
which may lower cholesterol and the risk of heart disease [82].  Phytosterols have been 
extracted from many seed oils using scCO2, as well as other natural sources, such as bee 
pollen [83]. 
Along with fatty acids, the other subgroup of lipids is glycerides, which include 
waxes, triglycerides, and phospholipids [74].  Phospholipids are of particular interest for 
scCO2-based decellularization, as they are a primary component of cell membranes.  
However, phospholipids have been studied in much less detail than fatty acids, likely 
because their high polarity makes them more difficult to extract.  Still, some progress has 
been made in this area.  Tanaka et al. were able to extract phospholipids from salmon roe 
with up to 80% purity, though high concentrations of added ethanol were needed [84].  
Phosphatidylcholine has been extracted from inedible egg parts with scCO2, but a two-
step process was required and yield still was relatively low (< 50 g/kg) [85].  More 
recently, phospholipids were extracted from activated sludge using scCO2 to assess soil 
quality [86].  However, more work is needed to determine if extraction of cell membrane 
components is a viable approach to decellularization. 
 
  
19 
 
2.1.3 Sterilization 
 TE scaffolds must be sterilized before implantation, as hospital patients have an 
elevated risk of nosocomial infection because of weakened immune systems, close 
quarters, and the necessity of invasive procedures and implements [87].  This risk is 
especially high in intensive care units [88].  Thus, sterilization of all medical devices and 
implants is critical for patient safety.  Numerous methods exist to sterilize materials, but 
most have one or more significant drawbacks for a biomedical application.  The high 
temperature and humidity of steam autoclaving can denature proteins and damage fibrous 
and polymeric materials [89].  Ethylene oxide is toxic, flammable, and possibly 
carcinogenic [90].  Gamma irradiation has been shown to cause unwanted changes in the 
molecular weight, glass transition temperature, and water content of TE biomaterials 
[91].  Liquid sterilants such as phenols, glutaraldehyde, and peracetic acid are eye and 
skin irritants with varying degrees of toxicity [92]. 
 Dense-phase CO2 is often used for sterilization of biomaterials because it does not 
present any of these drawbacks.  Spilimbergo’s group has done extensive work on the 
mechanisms of cell deactivation by scCO2.  Through in situ fluorescence staining, they 
have shown that cell death primarily occurs from CO2 permeation of the lipid bilayer in 
the cell membrane [93].  CO2 enters the cell, lowering cellular pH and deactivating 
enzymes [94, 95].  Bacterial spores are typically more difficult to kill than vegetative 
bacteria.  Our group showed using transmission electron microscopy that scCO2 damages 
the spore envelope, but a lethal oxidizing additive, such as hydrogen peroxide, must then 
be absorbed by the cell to complete the deactivation process [35].  Pressure cycling 
and/or electric pulses also improve spore deactivation [44]. 
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 The parameters required to achieve sterilization are or at least high-level 
disinfection (which does not require removal of spores) are somewhat application-
dependent, but usually the supercritical CO2 phase is used.  A temperature of 40°C or 
above and a pressure of 20 MPa or higher (or a more moderate 8-15 MPa range with 
pressure cycling) are usually adequate [44].  Deactivation of vegetative bacteria and 
bacterial spores from biomaterials using scCO2 has been demonstrated numerous times 
by our group and many others [34, 96, 97], and is also commonly done in pasteurization 
and food processing [22, 98].  However, comparatively little work has been done on virus 
deactivation with scCO2.  In the late 1990s, Larzul’s group used scCO2 to remove viruses 
from bone allografts, though three additional processing steps were required after scCO2 
treatment to achieve high levels of virus deactivation [99].  Recently, nitrous oxide (N2O) 
and fluorocarbons have been proven more effective for virus removal under most 
circumstances, possibly because N2O is pH neutral instead of acidic [44].  N2O has 
similar critical conditions like CO2, but is often avoided because of safety concerns; it is 
strong oxidizer that can cause explosions in the presence of an organic fuel source [100]. 
   The microbial removal properties of supercritical CO2 also extend beyond viruses 
and bacteria.  Exploratory research has shown potential for supercritical CO2 in pest 
control during food storage [101].  In our lab, the solubility of tea tree, hinoki, and cedar 
wood oils in supercritical CO2 has been utilized to create an acaricidal treatment on 
household objects for the prevention of asthma [102].  These technologies still have 
ample room for exploration and development. 
 Though supercritical is usually the preferred CO2 phase, liquid CO2 has been used 
in some sterilization applications.  There are three situations that make liquid CO2 
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particularly desirable for an application: (1) when cost of equipment is a limiting factor, 
(2) when the higher pressures and temperatures required by the supercritical phase would 
be deleterious, or (3) when surfactant additives are used, since their solubility in CO2 is 
often inversely proportional with temperature [53, 103].  In our group, Jimenez et al. 
were able to use liquid CO2 to completely sterilize a model hydrogel [32], and Tarafa et 
al. successfully removed bacterial endotoxin from titanium disks using water, liquid CO2, 
and commercial surfactant Dehypon Ls-54 [104, 105].  Liquid CO2 has also been used to 
sterilize textiles [52]. 
 For the purposes of this dissertation, it is worth noting that there are two 
publications where scCO2 was used to sterilize an acellular material.  In 2009, Qiu et al. 
used scCO2 to sterilize acellular porcine dermis [38].  Small pieces of ECM were 
sterilized using supercritical CO2 with a peracetic acid additive.  In under 30 minutes, 6 
log reduction was attained for Bacillus atrophaeus, a bacterial spore that has traditionally 
been analyzed for sterilization effectiveness [31, 35].  They also studied removal of 
encephalomyocarditis (EMC) and other viruses, and attained complete virus removal in 
15 minutes of scCO2 treatment, which was more effective than two hours of treatment in 
peracetic acid alone.  Additionally, scCO2 treatment caused less than a 2% change in 
matrix weight, showing a relatively mild impact of treatment.  Balestrini et al. similarly 
utilized scCO2 to sterilize acellular lung ECM while maintaining key scaffold properties 
[39].  Supercritical CO2 appears to have considerable potential for ECM sterilization, but 
more research is needed, particularly on larger or three-dimensional samples.  This 
research may soon occur given the recent classification of xenogeneic scaffolds as 
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medical devices by the United States Food and Drug Administration (FDA), thereby 
requiring terminal sterilization prior to clinical use [106]. 
 
2.1.4 Synthetic TE Scaffolds 
 CO2 has long been known to create pores in polymeric substances during 
depressurization, even in the gaseous phase.  This process is often called polymer 
foaming, and it occurs because CO2 plasticizes the polymer, liquefying it and increasing 
its density.  Upon depressurization, CO2 nucleates and forms gas bubbles when leaving 
the polymer, creating a pore network [107].  Two main criteria are necessary for a 
polymer to undergo this process: (1) moderate to high affinity for CO2 and (2) a glass 
transition temperature below the processing temperature [108]. 
 Careful manipulation of process variables, such as pressure, treatment time, and 
depressurization rate, can lead to predictable porosity and average pore size of the treated 
biomaterial.  A groundbreaking paper demonstrating this was published by Howdle’s 
group in 2007 [29].  They studied scCO2 foaming of poly(lactic acid), PLA, and 
poly(lactic-co-glycolic acid), PLGA, in considerable depth.  Their work included a 
factorial design of temperature, pressure, molecular weight, glycolic acid concentration, 
depressurization rate, and treatment time.  They found increasing temperature and 
depressurization rate to be directly proportional to pore size, while increasing pressure, 
treatment time, molecular weight, and glycolic acid concentration were indirectly 
proportional to pore size.  Porosity was in the acceptably high 70-80% range in most 
cases, except for very high glycolic acid concentrations, where it decreased considerably.  
A more uniform pore size distribution was found for scCO2 compared to gaseous CO2, 
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likely because the higher diffusivity in the supercritical state creates a more uniform 
distribution of CO2 within the plasticized polymer. 
 Recently, the use of inert particulate additives and CO2/water/surfactant 
emulsions has considerably improved pore interconnectivity, overcoming a significant 
barrier to the viability of scaffolds fabricated using this technique [42].  CO2 has also 
been used to augment other scaffold fabrication methods, including emulsion templating 
[109], microsphere sintering [110], phase inversion [111], electrospinning [112], and 
biomolecule impregnation [113].   
 Another concern during any scaffold treatment is loss of bioactivity caused by 
chemical reactions that alter surface chemistry.  Loss of bioactivity could inhibit cellular 
function or cell adhesion to a scaffold.  However, scCO2 is relatively inert and has been 
shown to not adversely affect bioactivity of both synthetic bone scaffolds and essential 
oil extracts [114, 115].  Still, establishing bioactivity of a natural scaffold after scCO2 
treatment would be an important step. 
 Since CO2 also can be used to sterilize TE scaffolds, the amount of processing 
steps can potentially be reduced by using CO2 to both form and sterilize the scaffold [33].  
Like with extraction and sterilization, the supercritical phase is much more commonly 
used in scaffold treatment, but liquid CO2 has been shown to have compatibility with 
some synthetic polymers, particularly ones with higher crystallinity [116].  CO2 sorption 
is so high in amorphous materials that it often causes irreversible effects from extreme 
amounts of swelling; the compatibility of CO2 crystalline materials is likely caused by 
their reduced free volume compared to amorphous materials [117]. 
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 Very little work has been done on CO2 and natural polymers, including potential 
TE scaffold biomaterials.  Though supercritical CO2 has been applied sparingly to leather 
processing in the past decade [118, 119], to our knowledge no work has been done prior 
to this dissertation on the fundamental interactions of collagen and dense-phase CO2.  
However, Reverchon’s group recently created chitosan aerogels by lyophilization, 
crosslinked them with glutaraldehyde, and then removed almost all glutaraldehyde (final 
concentration below 0.1 ppm) using scCO2 and ethanol [41, 120].  This clearly presents 
an opportunity for scCO2 in crosslinking of naturally-derived scaffold materials.  Recent 
reviews in the decellularization field have also recognized the potential for sterilization 
ECM with scCO2 and recommend further research in the area [12, 13], but aside from the 
aforementioned sterilization work [38, 39], no literature is available on the subject. 
There is one publication where scCO2 is used in decellularization.  Sawada et al. 
used scCO2 and an ethanol additive to decellularize porcine aortas [43].  They reported 
100% removal of DNA and 80-90% removal of phospholipids at relatively mild pressures 
and temperatures.  However, problems with tissue dehydration, inability to completely 
rehydrate, loss of mechanical strength, and residual phospholipids were reported.  
Though this paper was published in 2008, to our knowledge no follow-up or similar 
studies have been published since.  Chapter 6 of this dissertation includes our efforts to 
replicate and improve upon Sawada’s findings. 
 
2.2 Natural Biomaterial TE Scaffolds 
 We now turn our attention to the broad topic of TE scaffold design and 
fabrication.  Two main routes exist for the fabrication of TE scaffolds: (1) synthetic 
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biomaterials, including synthetic polymers and composites, and (2) natural biomaterials.  
While the former path has scientific merit and does offer some advantages, it is beyond 
the scope of this dissertation and will not be discussed in greater detail.  For further 
reading on the subject of artificial TE matrices, the reader is encouraged to examine the 
thorough review by Cho’s group [47]. 
There are two primary avenues for production of TE scaffolds composed of 
natural biomaterials.  The first is scaffolds composed primarily of one major ECM 
protein, often collagen, which are formed into a desired shape and size by various 
methods (e.g. electrospinning, lyophilization, etc.) [121].  The other subgroup is scaffolds 
composed of ECM; these are created by decellularization of an animal tissue, with the 
resulting ECM being used as the scaffold [122].  A great amount of variation exists in the 
methods by which natural biomaterial TE scaffolds are produced.  Some of the most 
common and most pertinent to this work are explored in this subsection. 
 
2.2.1 Collagen Scaffolds 
The extracellular matrix gives structural support to cells, spatial cues for tissue 
growth, and direction for cell behaviors and functions [123].  These features all make 
collagen a desirable scaffold material.  Collagen is the most abundant protein in the ECM 
of most tissues; it therefore has numerous sources in the body and is an intuitive 
candidate for a natural biomaterial scaffold, especially if decellularization of the whole 
ECM is challenging [124].  Though having the entire ECM is ideal for promotion of 
constructive tissue remodeling [7, 125], collagen has been shown to regulate cell 
adhesion, migration, proliferation, and differentiation and is often easier to isolate [126]. 
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The advantages of collagen as a scaffold substrate are numerous.  In addition to 
its role in remodeling, collagen has low immunogenicity and antigenicity, is porous and 
permeable, and has controllable biodegradability based on its extent of crosslinking.  It 
also biodegrades in a more favorable way than many synthetic materials.  While synthetic 
materials degrade from an immune response mediated by macrophages, ECM proteins 
like collagen elicit a less aggressive immune response that is mediated by matrix 
metalloproteinases and growth factors, stimulating natural tissue growth during scaffold 
degradation [4]. 
There are also numerous sources of collagen available.  Human collagen can be 
harvested from the placenta [127], but most collagen traditionally comes from 
mammalian sources, including cow, pig, rat, and sheep.  More recently, fish collagen has 
also been purified from parts that are normally discarded [128].  Finally, studies have 
been done to produce recombinant collagen; this could be important if collagen scaffolds 
experience a significant rise in usage, as yields from animal sources are often low [129]. 
Some scaffolds are made from pure collagen, usually a combination of types I, II, 
and III, since these are most common in the human body.  One common fabrication 
method is lyophilization, or freeze-drying.  Lyophilization protocols involve placing a 
collagen gel or solution into a specific shape or mold, then freezing it and removing the 
water.  Scaffold properties can be manipulated by changing collagen concentration and 
freezing time [130].  Another popular approach is electrospinning.  In this method, 
collagen is placed in a syringe or spinneret, charged with high voltage, and a jet 
eventually shoots at a grounded target once the potential difference is high enough, 
evaporating the solvent and creating a fiber [131].  These fibers can be manipulated into 
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various shapes and sizes.  Finally, extrusion methods utilize syringe pumps to flow 
collagen solutions into a desired shape or area.  Collagen can be extruded into different 
geometries based on the design of the extruder, such as the Yost group’s tubular design, 
which has been used to make TE scaffolds for heart, bone, and blood vessel tissues [4, 
132-134]. 
The main disadvantage of collagen as a scaffold material is that it lacks 
mechanical strength, especially when fully hydrated [121].  Collagen is often physically 
or chemically crosslinked to improve its mechanical strength.  Common physical 
crosslinking methods include dehydrothermal treatment and ultraviolet or gamma 
irradiation [135].  Chemical crosslinking has been traditionally done with glutaraldehyde 
or azides [136], but these chemicals are cytotoxic if not fully removed [18, 137].  Less 
hazardous crosslinkers have been pursued recently, including EDC [138], genipin [139], 
and riboflavin [140], but these alternatives may be less potent [141]. 
Instead of crosslinking, the mechanical strength of collagen can be strengthened 
by incorporating an additional material into the scaffold to create a collagen blend.  These 
materials include polymers, composites, and ceramics.  Some polymers, like poly(ε-
caprolactone) (PCL), are synthetic polymers used commonly in TE and add mechanical 
strength and control over degradation rate [142].  Natural polymers are used as well; for 
example, silk fibroin adds mechanical strength to collagen and also provides extra 
adhesion sites during cell seeding.  For example, Wei et al. used a collagen/PCL/silk 
fibroin blend to create a bladder scaffold that promoted proliferation of epithelial cells 
[143].  Other common blending materials include hydroxyapatite, a ceramic often used in 
bone tissue scaffolds for its osteoinductivity [144], and carbon nanotubes, which can 
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increase scaffold stiffness and promote cell differentiation [145].  Growth factors can also 
be incorporated into collagen scaffolds, particularly during electrospinning [146]. 
 
2.2.2 Decellularized ECM Scaffolds 
Decellularized scaffolds are fabricated by removing DNA and cellular matter 
from an animal tissue and using the recovered ECM as a TE scaffold.  The primary 
benefits of ECM scaffolds are low immunogenicity and the capacity for constructive 
remodeling after recellularization [5-7, 125].  Constructive remodeling involves the 
development of nerves, vasculature, and proper tissue function after a scaffold is 
implanted.  It occurs as a result of an anti-inflammatory immune response mediated by 
Th2 helper cells and M2 macrophages, rather than the pro-inflammatory Th1 cells and 
M1 macrophages normally observed in the deposition of scar tissue [106].  This type of 
response is associated with ECM scaffolds specifically [147, 148]. 
Decellularization has been performed on almost every tissue in the body, 
including adipose [149], bladder [150], blood vessel [151], bone [152], brain [153], 
cornea [154], esophagus [155], heart [156], intestine [157], kidney [158], liver [159], 
lung [160], nerve [161], skin [162], trachea [163], and others.  Decellularized tissues 
originate from several different mammalian sources, most commonly porcine, bovine, 
ovine, or murine, among others [13].  There are numerous decellularization methods and 
agents, but decellularization techniques are usually categorized as physical, chemical, 
enzymatic, or a combination of the three [12]. 
Chemical treatment often involves removal of cells with chemical detergents 
(surfactants).  The two most common detergents are sodium dodecyl sulfate (SDS) and 
  
29 
 
Triton X-100; they are nearly ubiquitous in the field.  SDS is an ionic detergent and 
functions by solubilizing DNA and lipid membranes, as well as disrupting covalent 
protein-protein bonds.  The main drawbacks of SDS are residual cytotoxicity and 
disruption of glycosaminoglycans (GAGs) and other ECM molecules [122, 164].  Triton 
X-100 is a non-ionic detergent that solubilizes proteins; it is less disruptive to ECM, but 
fails to decellularize denser tissues [165].  Zwitterionic detergents, such as tributyl 
phosphate [166] and CHAPS [160], maintain the native charge and state of proteins and 
are often effective in decellularizing thin tissues.  Any detergent will eventually cause 
ECM degradation, so they are usually limited to very low concentrations and/or short 
treatment times [167].  Chemical treatment can also include acids, bases, or organic 
solvents, though these can significantly alter ECM mechanical properties and chemical 
composition and are less common [155, 168].  Of particular note for this study is 
Lumpkins’ use of ethanol in decellularization.  As in Sawada’s work, considerable 
dehydration was reported, with ECM stiffness increasing threefold [168]. 
Biological agents can destroy and remove cellular material from tissues.  In 
particular, certain enzymes can break the bonds in large organic molecules, such as 
peptides and nucleotides.  For example, in adipose decellularization, Choi et al. used 
DNase and RNase in conjunction with SDS to achieve more complete decellularization 
than SDS alone [149].  Chelating agents, such as EDTA, can aid cell removal by 
increasing membrane permeability and by breaking adhesions between cells and the 
ECM via disruption of calcium transfer [169]. 
Finally, physical treatment can be used to detach cells from the ECM.  Agitation 
and sonication are used to burst cells or dislodge them from the ECM [15, 170].  High 
  
30 
 
hydrostatic pressure (HHP) followed by extended washing has been used to decellularize 
aortic tissue [171], suggesting potential for scCO2 in decellularization, as its pressure is 
far lower than HHP.  Another common physical treatment is electroporation, where cell 
membranes are lysed by electrical pulses [172, 173].  These and other physical 
decellularization methods, such as temperature treatment and pressure gradients, are 
described in greater detail by Keane et al. [13]. 
Of particular note for this dissertation is the decellularization of blood vessels by 
Simionescu’s group [151, 174, 175].  In particular, they have had considerable success 
with immersion decellularization of aorta and aortic roots using a 16-day treatment of 
SDS, Triton X-100, sodium deoxycholate, and EDTA followed by 4 days of enzymatic 
treatment.  The resulting ECM was acellular and responded well to biaxial mechanical 
testing [17].  The group also created elastin scaffolds for arterial TE in diabetic patients 
by decellularizing in sodium hydroxide, which removed most of the collagen [9].   
Though these scaffolds are of excellent quality, they are time-consuming to produce.  If 
successful, scCO2 decellularization would offer a significant reduction in treatment time. 
The term “decellularization” once referred primarily to the treatment of tissues, 
small layers of cells that compose part of an organ.  Now, much research is being done on 
whole-organ decellularization.  This potentially represents a great improvement in 
fabrication efficiency because macroscopically large volumes can be decellularized using 
just one treatment process, with the ultimate objective being the ability to engineer and 
mass-produce entire organs for patients in need of organ transplants [176].  Most whole-
organ decellularization processes use a technique called perfusion to apply the 
decellularizing agent.  A perfusion system involves connecting a small tube to the native 
  
31 
 
vasculature (e.g. Baptista et al. chose the portal vein in whole liver decellularization 
[159]) and then applying a small flow (usually on the order of 1 mL/min) of one or more 
decellularizing agents throughout the organ’s vasculature for several hours or days [177].  
This can uniformly decellularize a three-dimensional structure.  Recellularization has 
proven extremely challenging, but is usually attempted using a perfusion bioreactor with 
cell media. 
Because of the many different treatment types and the lack of universal standards 
for both decellularization and ECM properties, it is difficult to compare different 
decellularization protocols and results.  The characteristics of a successfully 
decellularized tissue or organ are generally agreed upon in the field – the material should 
be (1) acellular, (2) sterile, and of the same (3) mechanical strength (4) biochemical 
composition and bioactivity as before treatment.  Yet, there is little-to-no agreement on 
quantitative standards to determine if these criteria have been met, and the ability to 
confirm decellularization is critical given the severe inflammation and rejection caused 
by implantation of an incompletely decellularized construct [10]. 
Crapo et al. addressed this lack of a universal standard in their 2011 
decellularization review [12], and suggested the following characteristics to define a fully 
decellularized material: 
1. Less than 50 ng of double-stranded DNA per mg ECM (dry weight) 
2. DNA fragment length of less than 200 base pairs 
3. No “visible nuclear material” after DAPI and/or H&E staining 
However, this has yet to become a widespread standard, and in their words the standard 
“may be too stringent, sufficient, or too liberal.”  Furthermore, this decellularization 
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standard only addresses the first of the four points mentioned above.  Desired sterility of 
implanted medical devices, including xenogeneic scaffolds, has been established by the 
FDA at 6 log reduction of pathogens [37].  However, quantitative standards on the 
mechanical and biochemical properties of decellularized scaffolds are still needed. 
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Chapter 3 Fundamental Interactions of Type I Collagen and Dense-Phase CO2
3.1 Introduction 
Collagen is the most abundant protein in the human body and has been studied at 
length as a biomaterial for TE scaffolds [121].  Some common methods for fabricating 
collagen scaffolds include electrospinning [146], lyophilization [130], extrusion [8], and 
gelation [178].  The advantages of collagen scaffolds are numerous.  Collagen is a key 
player in tissue growth and remodeling, having been shown to direct cell adhesion, 
migration, and proliferation [126].  Collagen has low immunogenicity and antigenicity, is 
porous and permeable, and its biodegradation rate can be controlled by the extent of 
crosslinking [123].  It also elicits an anti-inflammatory immune response rather than the 
pro-inflammatory response of many synthetics [4].  There are numerous sources of 
collagen available, including mammalian [179], fish [128], and recombinant [129]. 
The main disadvantage of collagen as a scaffold material is that it lacks adequate 
mechanical strength, especially when hydrated [121].  For this reason, collagen is often 
treated improve its mechanical strength; in fact, collagen has been treated ever since the 
first production of leather many decades ago [180].  One approach is material blending, 
the addition of a second biomaterial to improve mechanical strength.  The primary 
advantage of material blending is that it allows the engineer to tailor the properties of the 
scaffold based on the properties of the material chosen.  Materials commonly added 
include natural polymers like silk fibroin [181], synthetic polymers like
34 
poly(ε-caprolactone) [142], carbon fibers or nanotubes [182], and ceramics such as 
hydroxyapatite [144]. 
Collagen is also commonly processed using solvents.  One reason for such 
treatment is crosslinking, which improves the mechanical strength of collagen without the 
need of material blending.  Physical crosslinking is accomplished by ultraviolet 
irradiation or dehydrothermal treatment [135].  Also quite common is chemical 
crosslinking, often done with glutaraldehyde [136].  However, glutaraldehyde is 
cytotoxic if not fully removed [18], and the removal process is often difficult.  Less 
hazardous crosslinkers have also been pursued recently, including carbodiimides [138], 
genipin [139], and riboflavin [140].  Collagen is treated with alcohols and phenols in 
other applications, but these compounds can affect the thermal and conformational 
stability of the collagen triple helix [183]. 
Given the extensive amount of collagen processing that occurs, novel solvents 
could significantly benefit the field.  One solvent that we feel has been overlooked is 
supercritical CO2.  Below its critical temperature and pressure, a pure fluid can exist in 
two-phase vapor-liquid equilibrium.  But upon exceeding the critical values, a pure fluid 
exists as a one-phase supercritical fluid.  Supercritical fluids have low diffusivities and 
viscosities like gases, but high densities like liquids; these properties make them desirable 
solvents [21].  Supercritical CO2 is of particular interest because of its unusually low 
critical temperature of 31.1°C, allowing treatment of biomaterials at physiologic 
temperature (37°C).  CO2 is also non-toxic, non-flammable, chemically inert, and readily 
available.  Supercritical CO2 has already been utilized in a number of other biomedical 
applications, including extraction of biomolecules [25, 73, 80], polymer foaming [28, 
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29], decellularization [43], and sterilization, a focus area for our group [30-37, 104, 116].  
Additionally, Reverchon’s group recently used scCO2 to extract residual glutaraldehyde 
from a crosslinked chitosan aerogel [41]; the same is almost certainly possible for 
collagen scaffolds. 
Very few published reports of scCO2 treatment of collagen exist, and they are 
very development-oriented, such as sterilization of collagen sponges [184] and infusion 
of transglutaminase into leather [185].  To our knowledge, no one has studied the 
fundamental interactions between collagen and scCO2 or assessed their chemical 
compatibility.  Chemical compatibility exists if two molecules do not react when one is 
exposed to the other, and if exposure does not cause thermal phase changes in one or both 
species (in the specific case of proteins, the phase change is denaturation) [186, 187].  
Additionally, there has been no published study on treatment of collagen with liquid CO2.  
CO2 in the liquid phase can be desirable for applications constrained by equipment cost 
or the higher temperatures or pressures needed for scCO2. [32, 33, 104].  Liquid CO2 is 
known to be compatible with crystalline synthetic polymers [116], making collagen a 
likely candidate for liquid CO2 compatibility given its high crystallinity. 
The objective of this study is to observe how the native collagen triple helical 
structure responds to treatment with liquid and supercritical CO2.  This will be done by 
analysis of three properties before and after CO2 treatment: (1) thermal stability, (2) 
molecular weight distribution, and (3) changes in secondary structure.  After establishing 
how dense-phase CO2 and collagen interact, viable applications for CO2 processing of 
collagen will be elucidated. 
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3.2 Materials and Methods 
The experiments performed were chosen to determine how liquid and 
supercritical CO2 affect the physical and biochemical properties of type I collagen. 
 
3.2.1 Collagen Fiber Extrusion 
A 1% (w/v) type I bovine corium collagen dispersion in water was obtained from 
the Yost group (Medical University of South Carolina, Charleston, SC), prepared in their 
lab as described previously [4].  The collagen was extruded into fibers based on the 
method of Dunn’s group [181].  An aliquot of collagen was thawed overnight at 4ºC and 
the pH was reduced to 2.4 using 1 M hydrochloric acid.  The collagen was vortexed once 
every 10 min for 30 min (3 times total) and then centrifuged at 5000 rpm for 15 min to 
degas.  During vortexing and centrifugation, a fiber formation buffer (FFB) was prepared.  
This buffer consisted of 0.135 M NaCl, 0.03 M N-[Tris(hydroxymethyl)methyl]-2-
aminoethanesulfonic acid (TES), and 0.03 M sodium phosphate dibasic heptahydrate 
(SPDH). The buffer was heated to 37ºC and sodium hydroxide pellets were added to 
increase the pH to 7.5. 
After collagen centrifugation, the FFB was poured into a Pyrex container with 
large surface area and the collagen dispersion was loaded into a syringe pump attached to 
1.59 mm (1/16 inch) diameter polyethylene tubing.  The collagen was then extruded 
through the tubing and into the FFB at a 0.1 mL/min flow rate.  The self-assembled 
fibers, usually 10-15 cm in length and 1.5 mm in diameter, rose to the surface from 
buoyancy forces.  After 10 minutes, the FFB was siphoned and replaced with isopropanol 
and the fibers were soaked for 4 hr to remove residual buffer.  Finally, fibers were 
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removed from the isopropanol and dried overnight under the tension of their own weight.  
Dried collagen fibers were stored at room temperature until CO2 treatment. 
 
3.2.2 Dense-Phase CO2 Treatment 
Collagen fibers were placed in a 25 mL cylindrical stainless steel pressure vessel 
with threaded endcaps (Waters Corp., Milford, MA) and secured in an upright position 
using small rare earth magnets prior to treatment with CO2.  Fibers were treated with 
dense-phase CO2 in one of two states: the liquid phase, 8 MPa and 10°C (ρCO2 = 0.903 
g/mL), or the supercritical phase, 20 MPa and 37°C (ρCO2 = 0.856 g/mL), under dynamic 
conditions (1 mL CO2/min). 
A schematic of the apparatus used can be viewed in Figure 3.1.  Bone-dry grade 
carbon dioxide (1) (99.8% purity with siphon tube, Airgas National Welders, Charlotte,  
NC) was compressed in a chilled syringe pump (3) (500 HP Series, ISCO Inc., Lincoln, 
NE) and slowly injected into the pressure vessel (4), which was maintained at the desired 
temperature by the environmental chamber (5) (ESPEC Corp. LU-113, Osaka, Japan).  
The pressure in the vessel was maintained by a back-pressure regulator (6) (TESCOM, 
Elk River, MN).  After 1 hr of exposure to CO2, the system was depressurized at a 
controlled rate of 0.34 MPa/min (50 psi/min) using a manual hand pump (7) (High 
Pressure Co., Erie, PA).  Valves and fittings rated for pressures up to 68.9 MPa (2) (High 
Pressure Co., Erie, PA) were used throughout the system.     
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Figure 3.1 – Collagen Fiber Testing Schematic: 1 – CO2 Supply; 2 – High Pressure  
Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation Chamber; 6 – 
Collagen Fiber; 7 – Manual Hand Pump; 8 – Pressure Gauge; 9 – Back-Pressure 
Regulator  
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3.2.3 Bicinchonic Acid Assay 
Protein concentrations of solutions used in the following sections were 
determined using the bicinchonic acid (BCA) assay.  To perform the BCA assay, 25 μL 
of a solution of unknown protein concentration was loaded into one or more wells in a 
96-well plate and mixed with 200 mL of the BCA working reagent (Thermo Scientific,  
Waltham, MA).  The unknown samples and a set of known bovine serum albumin (BSA) 
standards were scanned at 562 nm with microplate reader.  Optical density readings of   
the BSA standards were used to create a standard curve, which was subsequently used to 
determine the concentration of the collagen solution. 
 
3.2.4 Differential Scanning Calorimetry (DSC) 
 Collagen fibers were characterized using DSC to ascertain possible changes in 
thermal stability caused by CO2 treatment.  After CO2 treatment, collagen fibers were 
dissolved in 4% v/v (0.7 M) acetic acid to create a collagen solution with 1 mg/mL 
collagen concentration.  Each solution was degassed for 15 min using a vacuum 
desiccator and magnetic stirring bar before testing.  After doing a baseline scan of acetic 
acid, the degassed collagen solution was carefully added to the sample port of the Nano 
DSC (TA Instruments, New Castle, DE).  The instrument was pressurized to 3 atm 
(gauge) and the sample was heated from 15 to 100°C at a rate of 2°C/min.  Data were 
recorded and analyzed with the NanoAnalyze software accompanying the instrument. 
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3.2.5 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
After CO2 treatment, collagen fibers were dissolved in 4% acetic acid.  Laemmli 
sample buffer (Bio-Rad, Hercules, CA), which contained 62.5 mM Tris-HCl (pH 6.8), 
2% SDS, 0.01% bromophenol blue, and 25% glycerol, was reduced with β-
mercaptoethanol (βME) to a βME concentration of 5% and then mixed with the four 
collagen solutions: untreated, liquid CO2-treated, scCO2-treated, and thermally denatured 
collagen (used as a control).  The solutions were heated for 10 min at 80˚C using a water 
bath. After cooling to ambient temperature, 10 μg of protein was loaded into the wells of 
a 4-15% acrylamide Mini Protean TGX gradient gel (Bio-Rad).  Running buffer (Tris-
Glycine buffer, Bio-Rad) was added and electrophoresis was conducted at a constant 100 
V until the dye front approached the bottom of the gel.  Precision Dual Color Standards 
(Bio-Rad) were used as molecular weight markers in the leftmost well. 
After electrophoresis, the gel was separated from the plastic cover and washed 
three times with deionized water for 5 min each.  The water was decanted and the gel was 
stained for 1 hr on an orbital shaker using 50 mL of Coomassie Brilliant Blue R-250 stain 
(Bio-Rad).  The gel was washed for 30 min in deionized water and then photographed to 
observe protein bands. 
 
3.2.6 Circular Dichroism (CD) 
The same collagen treatments studied in SDS-PAGE were dissolved in 10 mM 
sodium phosphate and studied using a CD spectropolarimeter (Jasco J-815, Oklahoma 
City, OK).  Collagen solutions were analyzed at concentrations of 10, 15, and 20 μg/mL, 
and a thermally-denatured collagen solution was used as a negative control. Nitrogen 
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flow set to 10 L/min.  After waiting 30 minutes for the xenon lamp to reach full power, 1 
mL of each collagen solution was added to a quartz cuvette.  CD scans were run at scan 
rates of 20 and 50 nm/sec over a 250-190 nm wavelength range.  Data were exported to 
Excel and saved to a USB drive. 
 
3.2.8 Statistical Analysis 
Graphs and tables show the mean value plus or minus one standard deviation.  A 
Student’s t-test was used to determine statistical differences between groups.  95% 
confidence (p < 0.05, indicated by *) was considered statistically significant, while 99% 
confidence (p < 0.01, indicated by **) was considered extremely significant. 
 
3.3 Results and Discussion 
 Though collagen processing and compressed CO2 have each garnered attention in 
the TE field, little is known about the fundamentals of how the two interact.  In this 
study, chemical compatibility of type I collagen with liquid and scCO2 was assessed by 
studying changes in thermal stability (DSC), molecular weight (SDS-PAGE), secondary 
structure (CD), and water content (vacuum drying).  If native collagen is chemically 
compatible with either or both CO2 treatments, then applied processing can be explored. 
Though chemical compatibility is studied directly, mechanical compatibility can also be 
inferred given the temperatures and pressures required for dense-phase CO2 to exist. 
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3.3.1 Thermal Stability  
 For CO2 to be practical in collagen processing, maintaining the thermal stability 
of the protein is crucial.  If collagen is denatured by heat, the crystalline regions collagen 
melt and it loses functionality like any other protein [188, 189].  Native collagen at 
mildly acidic pH is reported to denature at temperatures as low as 39-40°C [183].  This 
makes scCO2 treatment a concern because treatment at physiologic temperature (37°C) 
approaches this threshold. 
 The thermal stability of treated and native collagen was assessed by DSC.  A 
sample DSC thermogram of untreated collagen is shown in Figure 3.2.  This thermogram 
shows two characteristic peaks: a minor peak at 32-33°C and a major peak at 38-40°C, 
that were consistently observed in collagen denaturation.  This suggests a bimodal 
denaturation process, as recently observed by Staicu et al. under similar conditions [190].  
They propose that the initial small peak is caused by the disassembly of supramolecular 
complexes (i.e. separation of collagen molecules from one another) and the large second 
peak indicates the unfolding of each triple helical molecule into a random coil formation. 
Table 3.1 shows that scCO2 treatment does not have a significant impact on the 
height or temperature of either peak, indicating that the thermal stability of collagen is  
not substantially altered by scCO2 treatment.  This result indicates thermal compatibility, 
likely because the uncharged and nonpolar scCO2 does not disrupt the polar and charged 
amino acids in collagen.  However, Table 3.1 shows that liquid CO2 treatment 
significantly reduces the height of both peaks, and sometimes the smaller peak is not 
even observed.  This indicates considerable denaturation during treatment. 
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Figure 3.2 – Sample Thermogram of Collagen DSC: Thermogram of native collagen in 
4% acetic acid, 0.25 mg/mL.  The smaller initial peak represents the unfolding of 
supramolecular complexes, while the larger peak is the unfolding of the collagen 
molecule itself. 
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Table 3.1 – Collagen DSC – Native Collagen 
Treatment Minor T (°C) Minor Ht. 
(uW) 
Major T (°C) Major Ht. 
(uW) 
Native 33.1 ± 1.0 8.6 ± 2.5 38.5 ± 0.5 58.6 ± 12.0 
Supercritical 33.3 ± 0.3 10.4 ± 3.8 38.3 ± 0.6 47.5 ± 9.7 
Liquid 34.2^ ± N/A 3.9^ ± N/A 39.1 ± 0.3 10.5** ± 6.6 
 
^Peak only observed once; the height value of zero was used for other runs. 
** p < 0.01 compared to native collagen  
  
45 
 
This finding is surprising, as our previous work with liquid CO2 at room 
temperature indicated that crystalline polymers tend to be compatible with liquid CO2 
[116].  Furthermore, the liquid CO2 treatment was done at milder conditions than scCO2.   
However, the temperature in this work was 10-15°C below room temperature.  At first 
glance, a temperature difference of only 10-20°C seems unlikely to cause such a drastic 
change in thermal stability, but further consideration of collagen chemistry reveals 
several consequences of the temperature difference.  Temperature is the most notable 
factor in protein denaturation, but pH and salt concentration also play a role [191, 192].  
Since water is present internally within the collagen structure [179, 193], CO2 forms 
carbonic acid in the presence of water, causing a significant pH reduction.  Recent studies 
have shown that collagen is stable at mild pH but denatures readily at high acidity or 
basicity [194].  pH depression by CO2 may be exacerbated at lower temperatures because 
the solubility of CO2 in water is inversely proportional with temperature. 
Although protein denaturing by heating is done routinely, a similar phenomenon 
by cooling, called cold denaturation, also exists for many proteins [195].  Other studies 
have shown that long-term freezing of collagen negatively affects its thermal properties, 
including reducing its heat denaturing temperature by over a degree Celsius [196].  CO2 
density also increases at lower temperatures.  However, the liquid CO2 temperature used 
in this study was above freezing, and cold denaturation is more commonly observed in 
globular proteins [197], so internal pH drop is more likely to be the driving force of the 
observed denaturation during liquid CO2 treatment.   
It was hypothesized that repeating liquid CO2 treatment at a higher temperature 
would significantly reduce or even eliminate collagen denaturation, and preliminary 
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research indicates that this is the case.  DSC of a collagen fiber treated with liquid CO2 at 
25°C indicated much less denaturation (see Appendix A).  If raising the process 
temperature is not feasible, a basic additive, such as ammonia, could also counteract the 
pH drop caused by the interaction of liquid CO2 and water. 
 
3.3.2 Molecular Weight  
The effect of CO2 treatment on the molecular weight of collagen was determined 
by gel electrophoresis.  Native type 1 collagen would be expected to show a doublet at 
139 and 129 kDa, indicating the presence of the α-1 and α-2 helices, and possibly to show 
a double helix β-band at 258-288 kDa  [198].  On Figure 3.3, a band between 150 and 
125 kDa is clearly observed for untreated collagen and both CO2 treatments.  There is no  
Clear band visible above 250 kDa, which indicates that the collagen is broken down into 
individual α-helices during the preparation step.  Comparison of lanes 3, 5, and 7 to the 
large smear (rather than bands) in lane 9 shows that neither CO2 treatment completely 
denatures the protein. 
Though an α-helix band is clearly observed in Figure 3.3, it is unclear in the 
figure if there is one band or two in the 130-140 kDa region.  Magnified images of lane 7 
are shown in Figure 3.4.  A doublet is somewhat observable in image (a), but becomes  
very clear upon image enhancement in image (b).  As expected, the first band, for the α-1 
helix at 139 kDa, is about twice the size of the α-2 band at 129 kDa.  Overall, the SDS-
PAGE results show that both supercritical and liquid CO2 treatment do not have a 
significant effect on the molecular weight distribution of collagen. 
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Figure 3.3 – SDS-PAGE Gel Stained with Coomassie Blue: Lane 1 – Protein Standards; 
Lane 3 – Untreated Collagen; Lane 5 – Supercritical CO2 Treatment; Lane 7 – Liquid 
CO2 Treatment; Lane 9 – Thermally-Denatured Collagen 
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Figure 3.4 – SDS-PAGE Doublet Close-Up: (a) Original photograph, (b) Enhanced 
photograph.  N is native collagen, L is liquid CO2 treatment, and SC is scCO2 treatment.  
Image (b) was enhanced by adjusting the contrast and color saturation levels in Adobe 
Photoshop.  Bands are observed for both the α-1 and α-2 helix present in type I collagen 
in native collagen and both CO2 treatments.  The α-1 band is roughly twice as large 
because type I collagen contains two α-1 helices and one α-2 helix. 
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3.3.3 Secondary Structure 
 The effects of CO2 treatment on the secondary structure of collagen were 
determined using circular dichroism (CD).  Normally, triple-helical collagen has a CD 
spectrum with a positive peak at 225 nm and a negative peak at 205 nm [183].  As 
collagen denatures, it shifts from helix conformation to a random coil.  The same four 
treatments used for SDS-PAGE were analyzed by CD in the ultraviolet range (190-250 
nm); CD spectra for each treatment at the 15 μg/mL concentration are shown in Figure 
3.5 (spectra at other concentrations are available in Appendix B).  For native collagen 
(blue), a positive peak is observed at 225 nm and a negative peak at 205 nm, as expected.  
In contrast, denatured collagen (red) is simply a flat line because denatured collagen has 
no secondary structure.  Mirroring the DSC findings, scCO2 treatment (green) has very 
little impact on the secondary structure, with very similar peak magnitudes and 
wavelengths to native collagen.  On the other hand, liquid CO2 treatment (yellow) causes 
significant changes to the CD spectrum: the magnitude of the positive peak is 
considerably less, and the negative peak is barely observable.  These changes suggest a 
conformational shift toward random coil, since the random coil conformation has a 
positive peak near 210 nm that would counteract with the negative peak observed at 205 
nm in native collagen [199].  
The finding that liquid CO2 disrupts collagen secondary structure may appear to 
contradict the SDS-PAGE findings, which indicated no protein damage by liquid CO2 
treatment, but this is not the case.  CD measures secondary structure, which is clearly 
disrupted by liquid CO2 treatment.  Proteins studied in SDS-PAGE, however, must be 
linearized for bands to form; i.e. their secondary structure must be fully removed 
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Figure 3.5 – Circular Dichroism Spectra of Collagen CO2 Treatments: In untreated triple 
helical collagen, a positive peak is observed at 225 nm and a negative peak at 205 nm.  
Similar results are observed for supercritical CO2 treatment, but response is dampened for 
liquid CO2 treatment.  Denatured collagen shows no peaks, as expected. 
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 (this is done with βME and the 10-minute heating step; see section 3.2.5).  Therefore, 
one can conclude that liquid CO2 treatment partially denatures collagen – i.e. it is 
disruptive enough to affect the secondary structure, but not enough to affect the primary 
structure. 
It is worth noting the large amount of CD scatter observed at wavelengths below 
200 nm.  This is a common problem with some CD buffer solutions, where a 
considerable amount of noise is encountered in the high frequency part of the ultraviolet 
region (usually between 180 and 200 nm).  Several attempts were made to reduce this 
noise, but they were unsuccessful in reducing the noise while still maintaining sharp 
peaks.  Fortunately, no characteristic collagen CD peaks are found in the low wavelength 
region for either the triple helix or random coil conformations, so the noise did not 
meaningfully affect data collection or results interpretation. 
  
3.4 Conclusions  
In this chapter, the effects of supercritical and liquid CO2 treatment on the 
chemical and physical properties of type I collagen fibers were investigated.  Analysis by 
differential scanning calorimetry found minimal alteration of collagen thermal stability 
by scCO2 treatment, but significant denaturation from liquid CO2 treatment.  This 
surprising result may be attributable to internal pH drop caused by the low temperature 
used during this treatment; preliminary data indicate better compatibility at higher 
temperatures. 
SDS-PAGE showed no significant changes in collagen molecular weight during 
either CO2 treatment, as the characteristic α-helix doublet was observed in both.  CD 
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spectra of scCO2-treated collagen showed only a small effect on peak height and no 
change in peak wavelength, but liquid CO2 treatment caused a significant reduction in 
peak height and also shifted the negative peak toward a higher wavelength, indicating a 
transition from helical conformation to random coil structure.  Again, this finding may be 
caused by the treatment temperature used. 
In summary, it can be concluded from this study that scCO2 and type I collagen 
are chemically compatible, and it would be sensible to consider utilization of scCO2 in 
more practical collagen processing applications, such as sterilization, scaffold production, 
and extraction of residual crosslinking agents.  Liquid CO2 partially denatures collagen at 
the conditions studied, though preliminary data indicates that increasing the temperature 
could improve compatibility.  Since the supercritical phase is generally preferred because 
of its superior transport properties, only scCO2 was studied for the remainder of this 
dissertation. 
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Chapter 4  Extracting Glutaraldehyde from Crosslinked Collagen with scCO2
4.1  Introduction 
Since the emergence of TE as a scientific field, collagen has been utilized in TE 
scaffolds [180].  Collagen is found ubiquitously throughout the human body and has very 
low immunogenicity and antigenicity.  Collagen can be molded into scaffolds of various 
sizes and morphologies in both the solid and liquid/gel state; some examples of this 
include electrospun scaffolds [200], lyophilized collagen [130], and collagen hydrogels 
[198].  These methods allow collagen scaffolds to be tailored to have a desired porosity 
and permeability.  Furthermore, collagen has been proven influential in orchestrating the 
adhesion, migration, and proliferation of cells during tissue growth [126].  Collagen 
scaffolds also evoke an anti-inflammatory wound healing immune response [4]. 
However, collagen does have one major weakness as a TE scaffold material: its 
lack of mechanical strength.  Because of this deficiency, untreated collagen is rarely used 
as the sole material in fabrication of TE scaffolds.  There are two approaches commonly 
utilized to circumvent this problem.  The first is blending collagen with another 
biomaterial [121].  A number of biomaterials have been used for this purpose, including 
natural polymers [201], synthetic polymers [142], carbon nanotubes [145], and ceramics 
[144].  This approach increases the mechanical strength, but risks increasing 
immunogenicity.  It also increases the complexity of scaffold design and post-fabrication 
processing steps, such as sterilization and removal of residuals. 
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The other approach is crosslinking collagen to augment its mechanical strength.  
Crosslinks are covalent bonds formed between adjacent polymer chains that increase the 
mechanical strength of a polymer.  Such bonding can be photo-activated using ultraviolet 
(UV) irradiation, but UV crosslinking can denature proteins and is ineffective for thick 
samples because of its non-uniform penetration depth [135].  Chemical crosslinking is 
often more effective; in particular, glutaraldehyde is a reagent that has been shown to 
achieve a high degree of crosslinking at relatively low concentrations [202].  However, 
residual glutaraldehyde is extremely cytotoxic.  Speer’s group showed that as little as 3 
ppm of glutaraldehyde in cell media can kill over 99% of fibroblasts [137], and 
glutaraldehyde is also a known carcinogen [203].  Crosslinked TE structures often must 
undergo a rigorous heating process to remove residual reagents; this can be unsuitable for 
the physical and biochemical properties of collagen scaffolds [204].  Recently, more 
attention has been given to alternative crosslinking agents, such as EDC [138], genipin 
[139], and riboflavin [140], but these are relatively unexplored and may be less potent 
than glutaraldehyde [141]. 
If residual glutaraldehyde were removed using a faster and less disruptive method, 
it could significantly benefit collagen TE research.  The objective of this study was to 
develop a process to extract residual glutaraldehyde from crosslinked collagen films 
using scCO2.  scCO2 is formed when pure CO2 is heated and pressurized above the 
critical conditions of 31.1°C and 7.38 MPa.  These relatively mild conditions are suitable 
for processing biomaterials.  In particular, scCO2 has been used to extract numerous 
biomolecules, including essential oils [26], caffeine [69], and fatty acids [205].  It has 
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also been used in several other biomedical applications, including critical point drying 
[57], pasteurization [23, 93], and sterilization [30-32, 34-37]. 
Recently, Reverchon’s group used scCO2 with an ethanol additive to extract 
residual glutaraldehyde from crosslinked chitosan aerogels [41].  They found that an 8 
hour CO2 treatment could reduce glutaraldehyde levels below 1 ppm, and in some cases 
even below 0.1 ppm.  This is a critical finding for gel TE, as the standard heating process 
to remove residual glutaraldehyde would exceed the glass transition temperature of the 
biomaterial and cause collapse of the aerogel structure.  An analogous finding for 
collagen TE would be of similar benefit. 
Additionally, it was desired to quantify any possible effects or alterations to the 
chemical and physical properties of crosslinked collagen caused by scCO2 treatment.  
This was accomplished by comparing the thermal stability and mechanical properties of 
treated films to untreated films.  Maintaining the thermal and mechanical properties of 
collagen during glutaraldehyde extraction is important for preserving scaffold 
functionality in downstream applications. 
 
4.2 Materials and Methods   
4.2.1 Fabrication of Collagen Films 
 A 1% (w/v) type I collagen dispersion was obtained from the Yost lab; it was 
prepared by their group as described previously [4].  Collagen films were prepared 
according to the protocol of Weadock et al [206].  1 M hydrochloric acid was added to 2 
mL aliquots of collagen until reaching pH 2.  The acidified collagen was poured into a 35 
mm diameter petri dish (BD Falcon, Tewksbury, MA), covered with aluminum foil, and 
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air-dried in a chemical fume hood for 48 hr.  The resulting dried film was then carefully 
removed using fine forceps, cut into 2 cm x 0.5 cm rectangular strips, and stored at room 
temperature pending further experimentation. 
 
4.2.2 Glutaraldehyde Crosslinking 
 To crosslink the films, a 25% (v/v) glutaraldehyde solution (TCI America, 
Portland, OR) was diluted with deionized water to either 0.25% or 1%, as desired.  The 
solution was vortexed for 1 min at high speed to ensure uniform mixing, then a collagen 
film strip was carefully immersed in the solution.  The film and glutaraldehyde solution 
were left undisturbed for 72 hr, then the film was removed and washed several times with 
deionized water before further treatment. 
 
4.2.3 Glutaraldehyde Extraction using scCO2  
Crosslinked collagen films were loaded into the treatment chamber of a two-
chamber scCO2 flow system, shown in Figure 4.1.  The main difference from Figure 3.1 
is the addition of a second high-pressure vessel (5).  Here, ethanol was mixed with scCO2 
until it was fully dissolved (no more than 1 min).  Then, the valve to the treatment 
chamber (6), which contains the collagen film to be treated (7), was opened, and scCO2 
flow was set to 2.5 mL/min (residence time: 4 min).  Design of the presaturation system 
is discussed in greater detail in Chapter 5.   
As done previously, the temperature was maintained at 37°C by the 
environmental chamber, (4), and the pressure of the scCO2 in the vessels was maintained 
at 20 MPa (2900 psi) using a back-pressure regulator (10).  A manual hand pump (8) was  
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Figure 4.1 – Glutaraldehyde Extraction Schematic: 1 – CO2 Supply; 2 – High Pressure 
Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation Chamber and 
Stirring Bar (ethanol additive); 6 – Treatment Chamber; 7 – Collagen Film; 8 – CO2 Hand 
Pump; 9 – Pressure Gauge; 10 – Back Pressure Regulator; 11 – Emergency Vent 
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used to depressurize the system at a rate of 0.34 MPa/min (50 psi/min).  Valves and 
fittings rated for pressures up to 68.9 MPa (2) were used throughout the system. 
As a control, glutaraldehyde was separately removed from crosslinked collagen films by 
heat treatment for 12 hr at 120°C using a vacuum oven according to the protocol of Yang 
et al [204]. 
 
4.2.4 Measurement of Residual Glutaraldehyde 
 The concentration of residual glutaraldehyde was measured using a 
spectrophotometric method first performed by Bigi et al. [207].  Crosslinked collagen 
films were placed in a quartz cuvette (VWR, Radnor, PA) before and after scCO2 
treatment.  The cuvette contained 3 mL phosphate buffered saline (PBS) with 0.1 M 
glycine.  The presence of glycine has been shown to counteract the gradual pH drop 
normally observed with proteins in PBS solutions. 
The cuvette was immediately placed into a UV/visible spectrophotometer 
(Beckman-Coulter DU 730, Brea, CA), which was utilized in Kinetic/Time mode to 
measure the optical density of the solution at 260 nm every 1 min.  Typically, 
glutaraldehyde was released from the film over the course of 2-4 hr.  Separately, a 
standard curve was generated for known concentrations of glutaraldehyde in the 
PBS/glycine solution; the standard curve was used to determine the unknown 
concentration of residual glutaraldehyde in each collagen film. 
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4.2.5 Differential Scanning Calorimetry 
 Crosslinked collagen films were studied before and after scCO2 treatment using 
DSC to analyze their thermal stability.  Films were dissolved in 4% acetic acid overnight 
under gentle stirring.  Collagen solutions were next degassed for 15 min using a vacuum 
desiccator and magnetic stirring bar.  The degassed collagen solution was pipetted into to 
the sample port of the DSC instrument after performing a baseline scan with acetic acid 
as the reference solution.  The instrument was pressurized to 3 atm (gauge pressure) and 
the sample was heated from 10 to 90°C at 2°C/min.  Data were obtained using 
instrument-associated RunDSC and NanoAnalyze software and then were exported to 
Excel for further analysis. 
 
4.2.6 Tensile Testing 
 A uniaxial tensile test to failure was used to analyze the modulus of elasticity 
(MOE) and ultimate tensile strength (UTS) of collagen films before and after scCO2 
treatment.  Collagen films were loaded onto a Bose 3230 Electroforce Biomechanical 
Tester (Bose Corp., Farmingham, MA) and one end was stretched at a rate of 0.01 mm/s 
until failure.  The accompanying Wintest 4.1 software was used to control the experiment 
and collect data, which was exported to Excel for further analysis. 
 
4.2.7 Statistical Analysis 
Graphs and tables display the mean value plus or minus one standard deviation.  
A Student’s t-test was used to determine statistical differences between groups.  95% 
confidence (p < 0.05, *) was considered statistically significant, while 99% confidence 
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was considered highly statistically significant (p < 0.01, **).  All experiments were 
performed in triplicate (n = 3) unless stated otherwise. 
 
4.3 Results and Discussion 
 Collagen films were prepared, crosslinked with glutaraldehyde, then either used 
as controls or treated with scCO2 for 1 hour to extract unreacted glutaraldehyde.  Treated 
films were examined for extent of glutaraldehyde removal and for any changes in their 
physical properties effected by scCO2 treatment. 
 
4.3.1 Glutaraldehyde Extraction 
 Figure 4.2 shows an example of transient glutaraldehyde release from collagen 
films before and after scCO2 treatment.  The concentration of glutaraldehyde plateaus 
after all residual glutaraldehyde has leached into the glycine solution.  In this example, it 
is clear that the glutaraldehyde concentration is far greater than the cytotoxic level prior 
to scCO2 treatment, but well below it afterwards.  Similar behavior was observed in all 
other runs.  Glutaraldehyde extraction with scCO2 was effective at both crosslinking 
concentrations, 0.25% and 1%, as seen in Figure 4.3.  Two key findings are noted.  First, 
and most importantly, scCO2/ethanol treatment removes over 95% of residual 
glutaraldehyde at both crosslinking concentrations.  The residual glutaraldehyde 
concentration after scCO2 treatment is below the reported cytotoxic threshold of 3 ppm in 
our experiments, though it should be noted that the magnitude of residual glutaraldehyde 
concentration is dependent on the mass of collagen and volume of PBS/glycine solution  
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Figure 4.2 – Example Glutaraldehyde Release Curves: Glutaraldehyde leaches from the 
collagen films at a linear rate until the concentration plateaus.  Far less glutaraldehyde is 
present in the collagen film after scCO2 treatment. 
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Figure 4.3 – Quantitation of Residual Glutaraldehyde: At both concentrations used, 
scCO2 extraction of glutaraldehyde reduces the residual concentration by over 95%. 
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used in the experiment.  Another interesting observation is that the similarity between the 
results observed for 0.25% and 1% glutaraldehyde crosslinking solutions.   
One would intuitively expect larger residual glutaraldehyde concentration when a 
larger concentration is used during crosslinking, but there are several possible  
explanations for this result.  For example, there may be surface porosity and/or mass 
transfer limitations.  Also, the results may be related to extent of crosslinking.  It is 
possible that all of the glutaraldehyde reacts for both solutions, i.e. neither 0.25% nor 1% 
glutaraldehyde is a high enough concentration to fully crosslink collagen.  Conversely, 
the opposite could also be true – the number of amine crosslinking reaction sites on 
collagen are limited [208], so if 0.25% glutaraldehyde fully crosslinks collagen, then 
increasing the concentration to 1% will have minimal effect.   
In their similar study, Baldino et al. found that increasing the mass of 
glutaraldehyde used during crosslinking led to more residual glutaraldehyde in the matrix 
after scCO2 treatment (pre-treatment glutaraldehyde concentrations were not reported) 
[41].  However, this increase was not significant until an extreme excess of 
glutaraldehyde was used, which could indicate incomplete crosslinking at higher 
glutaraldehyde concentrations or complete crosslinking even at low glutaraldehyde 
concentrations.  The validity of these theories, particularly those regarding reaction sites 
and extent of crosslinking, are elucidated by studying the physical properties of the 
collagen films after scCO2 treatment, especially DSC.  
 Another result worth further consideration is the rapid glutaraldehyde leaching 
observed in this work.  For example, Figure 4.2 depicts a trial where most of the residual 
glutaraldehyde leaches into the PBS/glycine solution in 60 minutes.  This calls into 
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question using scCO2 at all when glutaraldehyde can be removed just as quickly by the 
leaching method.  However, the duration of the leaching process is abnormally fast 
compared to other accounts.  Glutaraldehyde leaching is very slow when the residual 
concentration is below 1 ppm, sometimes taking 24 hr or longer [41, 207].  Such low 
glutaraldehyde concentrations are likely necessary to avoid cytotoxicity, as media 
concentrations above 3 ppm inhibit 99% of cells and concentrations as low as 0.5 ppm 
cause some amount of inhibition [137].  Also, the effects of exposing collagen to PBS 
and glycine are not confirmed to be benign; salt in particular can affect the thermal 
stability of collagen [192], whereas scCO2 is non-toxic and highly inert.  Finally, leaching 
of other crosslinking agents, such as genipin or riboflavin, would be even slower since 
they are larger molecules than glutaraldehyde.  For all these reasons, we believe scCO2 
has future viability as a crosslinking aid. 
 
4.3.2 Physical Property Analysis 
 The effect of scCO2 treatment on collagen film properties was studied using two 
analytical methods: DSC to assess changes in thermal stability, and uniaxial tensile 
testing to measure alterations in stiffness and tensile strength. 
The thermal stability of crosslinked collagen films was studied using DSC; peak 
heights and denaturing temperatures of crosslinked collagen in 4% acetic acid are listed 
in Table 4.1.  Compared to native collagen, crosslinked collagen has a much higher 
denaturation temperature and a reduced denaturing peak height.  The crosslinking process 
increases the thermal stability of the protein by introducing covalent bonds, thereby 
requiring a higher temperature to denature the protein.  However, the peak height is 
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reduced because breaking covalent crosslinks is an exothermic process, while protein 
unfolding is endothermic [202].  Table 4.1 reveals that scCO2 treatment does not affect 
the thermal stability of crosslinked collagen, but heat treatment reduces both peak height 
and denaturation temperature, the former being statistically significant.  It is noteworthy 
that after crosslinking, thermal collagen denaturation is no longer bimodal and only one 
peak is observed.  This is observed because in the crosslinked state, the collagen 
molecules do not separate from each another before unfolding because they are 
covalently bonded by the crosslinks, instead of being associated by electrostatic forces 
only [209].   
Uniaxial tensile testing was performed to determine the effects of crosslinking 
and scCO2 treatment on the mechanical properties of collagen films.  The MOE and UTS 
for each treatment can be found in Table 4.2.  Compared to native collagen, crosslinking 
caused a major increase in UTS and a lesser but still significant increase in MOE – this is 
expected and confirms the DSC findings that suggest a high extent of crosslinking. The 
more interesting result is that for scCO2-treated films, the UTS greatly increased with a 
lesser but still significant increase in MOE.  A likely explanation for this is dehydration is 
the addition of ethanol during scCO2 treatment.  Ethanol increases scCO2 polarity, 
improving solubility of the polar glutaraldehyde molecule (to our knowledge, solubility 
of glutaraldehyde in pure scCO2 is not documented, but chemistry of similar molecules 
suggests it is minimal).  Though ethanol improves glutaraldehyde solubility, it is also 
known to substantially increase extraction of water from biomaterials [43, 54]. 
The implications of biomaterial dehydration vary considerably depending on the 
material treated and the application. In Baldino’s work with chitosan aerogels, for  
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Table 4.1: Collagen DSC – Crosslinked Collagen 
Film Type Denaturation Temp. (°C) Peak Height (μW) 
Native 39.1 ± 0.4 30.1 ± 8.4 
Crosslinked 63.2** ± 0.2 10.0*± 1.9 
Crosslinked + scCO2 63.3** ± 0.5 10.6* ± 2.5 
Crosslinked + 12 hr heat 59.7** ± 2.7 3.9^ ± 1.8 
* p < 0.05 compared to native collagen 
**p < 0.01 compared to native collagen 
^p < 0.05 compared to crosslinked control 
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Table 4.2: Collagen Film Tensile Test Data   
Treatment Modulus (kPa) UTS (kPa) 
Native Collagen 838 ± 141 12.0 ± 2.7 
Glut. Crosslinked (72 hr) 1113 ± 220 281** ± 30 
Glut. + SC-CO2 1584* ± 404 1067** ± 211 
Glut. + 12 hr heating N/A^ N/A^ 
* p < 0.05 compared to native 
**p < 0.01 compared to native 
^Heat-treated samples were too damaged to be tested 
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example, dehydration is probably not a major concern (no mechanical testing was 
reported in their study), since air is used to purposely remove water from the gels.  In 
other applications, such as scaffold production for long-term storage, a dry product is  
acceptable or even desirable [210].  However, in a water-rich substrate like a hydrogel, 
this drying effect is potentially a major hindrance to scaffold function and/or mechanical 
properties [168].  We have developed a method to prevent dehydration of biomaterials 
during scCO2 treatment that could be applied to this system to prevent the drying 
phenomenon [211]; this method will be discussed in considerable detail in Chapter 5 in 
the context of tissue decellularization. 
It should be noted that the mechanical test performed has some limitations.  The 
assumption of a perfectly rectangular geometry used in calculations is not fully accurate 
for treated films; the crosslinking and CO2 treatment processes can cause warping around 
the edges of the films, distorting the original shape.  Also, most tissues undergo more 
complex stressed in vivo than the static uniaxial forces applied in this work.  Blood 
vessels, for example, undergo dynamic biaxial forces in both the axial and longitudinal 
directions that vary with regular changes in blood pressure [212].  Therefore, it is 
important to assess the mechanical properties of a tissue engineering scaffold or 
biomaterial based on the intended application.   
 
4.4 Conclusions 
 In this chapter, a novel scCO2 method for extracting residual glutaraldehyde from 
crosslinked type I collagen films was presented.  In one hour of scCO2 treatment, over 
95% of unreacted glutaraldehyde was removed from the films, reducing residual 
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glutaraldehyde levels below 1 ppm.  Very similar results were obtained when 0.25% and 
1% glutaraldehyde solutions were used to crosslink the films, likely because all possible 
reaction sites were utilized at both concentrations. 
 After scCO2 treatment, DSC and tensile testing were performed to determine any 
potential effects of scCO2 treatment on the thermal and mechanical properties of the 
collagen films.  The DSC response was essentially unchanged before and after CO2 
treatment in terms of both peak height and denaturation temperature, indicating that CO2 
treatment did not disrupt the thermal stability of the films.  Tensile testing caused a 
significant increase in stiffness compared to the control and an even greater increase in 
UTS, indicative of supercritical drying caused by the ethanol additive.  However, this 
finding may not be problematic in some applications, and recent work in our lab indicates 
that biomaterial dehydration is easily preventable if desired.  The availability of a fast, 
innocuous method for removing residual glutaraldehyde from crosslinked collagen films 
overcomes a significant problem presented in the collagen TE literature.  Moving 
forward, it will be important to assess scaffold biocompatibility after scCO2 treatment 
and to determine the efficacy of this method for substrates of varying composition, 
thickness, and morphology. 
70 
Chapter 5  Preventing Biomaterial Dehydration with scCO2 Presaturation
5.1 Introduction 
Currently in the United States, over 120,000 people are on the national waiting 
list for an organ transplant, and that number is rapidly increasing [1].  One way to address 
this problem is the implantation of artificial tissues and organs fabricated via tissue 
engineering (TE), which would reduce wait times and alleviate the current necessity for 
tissue and organ donors.  However, tissues, organs, and their corresponding extracellular 
matrices (ECM) are highly complex and differ considerably throughout the body, making 
the development of functional, biocompatible, and sterile biomaterials very challenging.  
Potential barriers in the development of both synthetic and naturally-derived scaffolds 
include dehydration, loss of mechanical strength, chemical alteration of the matrix 
structure, and residual cytotoxicity when some detergents are used [10, 20, 213]. 
One promising but underexplored method of fabricating TE scaffolds involves 
using a SCF as a solvent.  In particular, scCO2 is promising for biomedical applications. 
It is inexpensive, readily available, chemically inert, nontoxic, and nonflammable [21].  It 
has mild critical conditions of 31.1°C and 7.4 MPa, so processing biological materials 
can take place at or near physiologic temperature (37°C).  Equipment and processes 
utilizing scCO2 have already been demonstrated in extraction of biological compounds 
[25, 26, 76-78, 80-83], decellularization [43], pasteurization [22-24, 93-95], and in 
sterilization of medical devices [33, 104], hydrogels [32], and decellularized ECM [38, 
39].  Additionally, scCO2 has been used to aid in hydrogel and polymer foaming [29, 40, 
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42], crosslinking of chitosan hydrogels [41], and several other TE scaffold fabrication 
methods [109-113]. 
Because the scCO2 platform has such versatility, it is important to explore the 
fundamentals and mechanisms behind the various processes.  One issue reported has been 
undesired dehydration of biomaterials during scCO2 treatment.  Water has a small but 
appreciable solubility in scCO2, around 0.01 mole fraction at mild supercritical 
conditions [214], which causes gradual dehydration of a material in a dynamic scCO2 
system.  For example, Sawada et al. used scCO2 to decellularize porcine aorta [43].  They 
reported DNA and cellular removal that would be adequate for the preparation of a 
naturally-derived TE scaffold, but SCF extraction of volatile substances (primarily water) 
during treatment caused embrittlement of the ECM, potentially endangering its viability 
as a scaffold.  Because hydrogels also have very high water content, understanding and 
preventing unwanted water extraction from occurring is of great importance in processing 
both synthetic and naturally-derived biomaterials with scCO2. 
 The reported extraction of volatiles during CO2 treatment is not surprising.  In 
fact, this phenomenon is well-known and is the basis of critical point drying (CPD), a 
process commonly used in tissue engineering [54] and other applications, such as 
electronics processing [55] and scanning electron microscopy [57].  The primary 
advantage of CPD over conventional evaporative drying is that CPD avoids passing 
through the two-phase vapor-liquid region of the phase diagram.  Avoiding this region is 
desirable for delicate materials that can be damaged by the surface tension that exists at 
vapor-liquid interfaces [58].  However, in this application, it is desired to avoid any kind 
of drying. 
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In this chapter, we address a challenge that will be common to any process, 
namely, the unwanted removal of water and volatiles from soft biomaterials.  We 
hypothesize that dehydration caused by scCO2 treatment can be significantly reduced or 
even eliminated by presaturating scCO2 with water prior to treatment.  Establishing 
thermodynamic equilibrium between water and scCO2 will prevent volatile substances 
from being extracted.  The objectives of this chapter are as follows: (1) to construct an 
apparatus that can presaturate scCO2 with water (i.e. achieve dynamic total solubility of 
water), and (2) to compare the amount of water extracted from two model scaffolds, a 
poly(acrylic acid-co-acrylamide) hydrogel and porcine aorta tissue, using dry and 
presaturated scCO2.  Achieving these objectives will enable further development of 
scCO2-based TE and decellularization processes. 
 
5.2 Materials and Methods 
To prevent water extraction from porcine tissue it is necessary to first achieve 
dynamic thermodynamic equilibrium (i.e. complete saturation) between CO2 and water. 
The saturated CO2 phase is subsequently suitable for treating a TE matrix. The first 
experimental objective was to ensure that the CO2 was being fully saturated during the 
mixing process.  Achieving this goal is critical before attempting to decellularize a tissue.   
 
5.2.1 Apparatus Development and Validation 
 A schematic of the presaturation apparatus used is shown in Figure 5.1. The 
essential function is to contact flowing scCO2 with liquid water in a temperature-
controlled, high pressure vessel. The vessel (5) shown in Figure 5.1 is a 25 mL high 
pressure stainless steel view cell (Waters Corp., Milford, MA).  10 mL of deionized water 
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was added to the vessel prior to the start of each run.  The vessel was continuously 
agitated using a stirrer plate and magnetic stirring bar. Temperature was maintained at 
50°C by the environmental chamber, (4).  The pressure of scCO2 in the view cell was 
maintained at 13.8 MPa (2000 psi) using a back-pressure regulator (7). 
To validate apparatus function, liquid carbon dioxide (1) was compressed in a 
chilled syringe pump (3) and slowly bubbled into the high pressure vessel.  After waiting 
15 minutes for thorough mixing, the humidified scCO2 was then flowed at various rates 
(controlled by the syringe pump) through the vessel and then a cold trap (8), which was 
maintained at -70°C using an ethanol/dry ice bath to condense dissolved water as the CO2 
exited the system. 
The mass of the cold trap was measured after each experiment using an analytical 
mass balance (Mettler Toledo, Columbus, OH) to determine the amount of water 
dissolved in the scCO2 at each flow rate.  This process is called the dynamic solubility 
method, where one stream is continuously fed into the system and the temperature and 
pressure are controlled externally and kept constant [215].  Calibration of this apparatus 
required validation that scCO2 would be saturated at sufficiently low scCO2 flow rates.  It 
is known that as the flow rate of CO2 increases in a dynamic flow apparatus, the 
residence time becomes too short for complete presaturation.  Trials were conducted at 
varying CO2 mass flow rates (1, 2.5, 5, 10, 15, and 20 mL CO2/min; n = 4 for each flow 
rate) measured at the pump inlet (0°C, 13.8 MPa; ρCO2 = 0.994 g/mL).  Treatment time 
was varied for each flow rate to ensure the same mass of scCO2 was used in each trial.  
The equilibrium solubility of water in supercritical CO2 at 50°C and 13.8 MPa (ρCO2  
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Figure 5.1 – Presaturation Test Schematic: 1 – CO2 Supply; 2 – High Pressure Valve; 3 –  
Syringe Pump; 4 – Environmental Chamber; 5 – 25 mL High Pressure Vessel; 6 – 
Pressure Gauge; 7 – Back-Pressure Regulator; 8 – Cold Trap 
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=0.665 g/mL) was found to be 0.00837 mole fraction by interpolation of known data 
[214], and compared to the mole fraction of water dissolved in CO2 at each flow rate to 
calculate an observed mole fraction, yobs. 
 
5.2.2 Biomaterial Selection and Preparation  
To further investigate presaturation, we studied both a synthetic hydrogel and a 
natural tissue, porcine aorta.  The hydrogel was poly(acrylic acid-co-acrylamide) 
potassium salt (Sigma-Aldrich, St. Louis, MO), a hydrogel used previously to establish 
the ability of dense-phase CO2 to achieve sterilization within a porous matrix [32]. 
Hydrogel powder was hydrated in excess water at 4°C for 24 hr. Excess water was 
removed from each hydrogel specimen by drying for 15 minutes under a light vacuum, 
using filter paper and a Buchner funnel to remove free saline prior to weighing and 
treatment.  Each hydrogel specimen was blotted onto a nylon filter and sealed inside the 
treatment chamber prior to exposure to scCO2.  The weight of each gel specimen was 
approximately 0.2 g. 
Porcine heart was obtained from a local slaughterhouse, and the aorta was isolated 
and surrounding fatty tissue removed.  The aortic tissue was cut into rectangles 
(approximately 3 cm x 2 cm) and stored in phosphate-buffered saline (PBS) at 4°C for up 
to 48 hours prior to use.  Each specimen was dried for 15 minutes under a light vacuum 
using filter paper and a Buchner funnel.  The treatment ratio and other conditions used 
(including temperature, pressure, and depressurization rate) were chosen to be very 
similar to the conditions used by Sawada et al. to allow for comparison [43].  Drying in a 
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vacuum oven (37°C, 38.1 cm Hg vacuum) was used as a negative control; changes in 
mass were recorded after 1, 2, 3, 6, and 24 hr. 
 
5.2.3 Treatment of Hydrated Tissue Matrices 
All biomaterial treatments were performed using the apparatus shown in Figure 
5.2.  Compared to Figure 5.1, the primary addition is a second pressure cell, the 10 mL 
treatment chamber (6), which contained the biomaterial.  Also, a manually-operated 
pump (8) (Pressure Generator 62-6-10, High Pressure Equipment Co., Erie, PA) was 
connected to the treatment chamber; the manual pump enabled a slow, controlled 
depressurization rate of 0.34 MPa/min (50 psi/min) after treatment. 
Two treatments were conducted on each biomaterial: one using dry scCO2 (no 
water in the presaturation chamber) and the other using scCO2 presaturated with water (n 
= 4 for both treatments).  All treatments were performed at 13.8 MPa (2000 psi).  The 
temperature was held constant at either 37°C (ρCO2 = 0.769 g/mL) or 50°C (ρCO2 = 0.665 
g/mL, for hydrogel only).  Four runs were made at each temperature and state of scCO2 
hydration.  All biomaterials, regardless of initial mass, were subjected to a treatment ratio 
of 60 minutes of scCO2 flow (1 mL CO2/min) per 0.2 g of gel or tissue to account for 
small differences in individual masses. 
 
5.2.4 Statistical Analysis 
Graphs of data show the mean value plus or minus one standard deviation.  A 
Student’s t-test was used to determine statistical differences between groups.  95%  
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Figure 5.2 – Hydrogel and Tissue Dehydration Test Schematic: 1 – CO2 Supply; 2 – High 
Pressure Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation 
Chamber; 6 – Treatment Chamber; 7 – Sample; 8 – Hand Pump; 9 – Pressure 
Gauge; 10 – Back Pressure Regulator 
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confidence (p < 0.05, indicated by *) was considered to be statistically significant; 99% 
confidence (p < 0.01, indicated by **) was considered extremely significant. 
 
5.3 Results and Discussion 
5.3.1 Verification of Thermodynamic Equilibrium  
Validation of the apparatus was demonstrated by using a cold trap to collect 
dissolved water in the effluent stream. Validation data are presented in Figure 5.3.   
For each CO2 flow rate, an observed water mole fraction (yobs) was calculated from the 
moles of water collected in the cold trap and the moles of scCO2 pumped by the syringe 
pump.  The yobs value was compared to the known equilibrium solubility at the conditions 
studied, 0.00837 mole fraction.  Complete thermodynamic equilibrium between scCO2 
and water was achieved at flow rates of 5 mL CO2/min and below, as measured at the 
syringe pump.  At flow rates 5 mL/min and below, the effluent water mole fractions 
approach the equilibrium limit.  As the flow rate increases, the observed mole fraction 
decreases, indicating failure to equilibrate.  CO2 flow rates of 1 mL/min were used for the 
remainder of this work. 
 
5.3.2 Hydrogel Treatment  
 An important characteristic of tissues and organs is that they are highly hydrated.   
Hydrogels have long been studied as a biomaterial for the fabrication of TE scaffolds 
because of their high water content, three-dimensional structure, and their ability to be  
crosslinked and functionalized [216].  Hydrogels were chosen as a model scaffold for this 
study because they are composed primarily of water.  Treating a hydrogel with scCO2  
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Figure 5.3 – Validation of Phase Equilibrium: Complete presaturation is achieved at flow 
rates less than 5 mL/min. 
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allowed us to study the behavior of water and scCO2 in the system without potential 
interference from other compounds or variables. 
Hydrogels were treated with dry (control) and water-presaturated scCO2 at 13.8 
MPa and either 37 and 50°C.  Data from these experiments are summarized in Figure 5.4.   
At both temperatures, the average water retention was over 99% when scCO2 was 
presaturated with water, but only about 50% when dry scCO2 was used. 
Results from treating the hydrogel with scCO2 confirm the initial hypothesis.  The 
hypothesis was also observed visually, as the hydrogels appeared shrunken and partially 
collapsed after treatment with dry CO2, as shown in Figure 5.5.  The mass retention with 
dry scCO2 is slightly lower at 50°C, likely because both water vapor pressure and 
solubility in CO2 increase with temperature.  With presaturated scCO2, gel mass is 
maintained at both temperatures.   
One noticeable feature of Figure 5.4 is that the error bars for dry scCO2 treatment 
of the hydrogels are relatively large.  This is likely related to structural changes in the 
hydrogel as it dries.  Porous hydrogels like poly(acrylic acid-co-acrylamide) do not dry 
uniformly; surface tension effects change the shape of the gel as water molecules are lost 
[217].  Additionally, drying curves for this hydrogel were produced by our group in a 
previous CO2 sterilization study [32], and a period of sharp mass decline during the 
drying process was observed.  However, regardless of the specific amount of water lost 
during dry scCO2 treatment, Figure 5.4 clearly indicates that presaturating scCO2 
prevents water from being extracted from the hydrogels. 
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Figure 5.4 – scCO2 Treatment of Hydrogels at 13.8 MPa: Dry scCO2 (blue) extracted a 
substantial amount of water, while presaturated scCO2 (red) removed very little. 
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Figure 5.5 – Visual Appearance of Treated Hydrogels: (a) untreated hydrogel, (b) hydrogel 
treated with dry scCO2, (c) hydrogel treated with presaturated scCO2  
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5.3.3 Porcine Aorta Treatment 
Vacuum drying was used to produce a complete drying curve for porcine aorta 
tissue (n = 6), as shown in Figure 5.6, where dimensionless mass on the y-axis is the ratio 
of the mass measured at each time point to the original mass of the tissue.  Substantial  
water loss occurred during the first six hours, but afterward the loss of mass was 
insignificant.  Vacuum drying of the native tissue removed over half of the initial mass in 
the first hour, with a continually more gradual decline in mass over the next five hours 
until reaching slightly above 20% of the initial mass.  This is consistent with the known 
water content of porcine aorta, which is about 75% [218]. 
Results for control (dry scCO2) and presaturated scCO2 treatments of porcine 
aorta are shown in Figure 5.7.  The average mass retentions are 78.6% ± 4.6% with dry 
CO2 and 97.3% ± 1.4% with presaturated scCO2; this difference is highly significant.  It 
is evident from these results that using presaturated scCO2 considerably reduces the 
amount of mass lost during treatment, again confirming the initial hypothesis.  Visually, 
in Figure 5.8, the samples treated with presaturated scCO2 (image b) maintained the beige 
color of the native tissue (a), while specimens treated with dry scCO2 (c) experienced 
considerable darkening, particularly around the edges of the specimen.   
There is still some mass loss using presaturated scCO2, which indicates that a 
small amount of volatile substances other than water are extracted from the tissue.  This 
mass loss may be attributed to other extractable materials in the tissue.  While the aorta is 
primarily composed of water and polymeric materials like collagen and elastin, there are 
other materials present in trace amounts that may be extractable by scCO2.  Like most 
tissues, porcine aorta is known to contain lipids such as cholesterol [218]; these may  
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Figure 5.6 – Vacuum Drying of Porcine Aorta: Conditions were 37°C, 38.1 cm Hg (15 in. 
Hg) vacuum; over half the tissue mass was lost in the first hour. 
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Figure 5.7 – scCO2 Treatment of Porcine Aorta at 37°C, 13.8 MPa: Using presaturated CO2 
significantly increases mass retention. 
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Figure 5.8 – Visual Appearance of Treated Porcine Aorta. (a) untreated aorta; (b) aorta 
treated with presaturated CO2; (c) aorta treated with dry CO2; (d) vacuum-dried aorta 
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TE scaffold.  However, this has been done either with a scaffold material other than a 
decellularized tissue [41], and/or was done with the intention of long-term scaffold 
storage [120, 210].  After long-term storage, a scaffold would require rehydration before 
comprise the non-water extracted volatiles in the tissue, as scCO2 has been shown to be 
efficacious for the extraction of fatty acids and other lipids [205].  For further 
development, any additional volatiles of interest could be identified and, if maintaining  
their presence is important, removal could be prevented by pre-equilibration of scCO2, 
analogous to pre-equilibration with water.   
scCO2 treatment was found to cause less water removal than vacuum drying – 
Figure 5.9 shows where dry and presaturated scCO2 treatment lies on the vacuum drying 
curve.  Even dry scCO2 treatment causes much less drying than a vacuum treatment over 
the same time interval.  This finding was also confirmed visually, as shown in image (d) 
of Figure 5.8.  Vacuum drying caused tissues to become significantly darker in color, 
similar to dry scCO2 (image c), but also made the tissue far more brittle and translucent.   
As indicated by the square on Figure 5.9, only about one-third of the native water 
was extracted by dry CO2 treatment.  scCO2 drying is less severe than oven drying for 
two reasons.  First, the flowing scCO2 never allows equilibrium to be established between 
the fluid phase and the tissue matrix.  There is also mass transfer resistance within the 
tissue, which slows transfer of water from the tissue to the flowing scCO2.  However, 
though scCO2 drying is less pronounced than vacuum drying, unintentional water 
extraction on this level could still significantly hamper the effectiveness of a TE scaffold, 
so minimizing any drying caused by scCO2 is very important.   
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Figure 5.9 – Comparison of Vacuum Drying and scCO2 Treatment of Porcine Aorta.  The  
square represents the average tissue dehydration run with 1 hour of presaturated scCO2 
treatment (0.97), while the circle represents the average tissue dehydration run with 1 
hour of dry scCO2 treatment (0.78).  Both values are significantly larger than 1 hour of 
vacuum drying (0.46). 
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Finally, it should be noted that this work is focused on preventing unintentional 
drying during scCO2 treatment, and we are not making the claim that any scaffold dried 
during a scCO2 process or otherwise is immediately invalid or nonviable.  In fact, work 
has recently been published by other groups where scCO2 is used to intentionally dry a  
seeding and implantation.  In addition to adding another processing step, the rehydration 
process has been shown to not fully restore the original water content of the matrix 
because of irreversible changes in ECM microstructure [43, 210].   Therefore, we 
maintain that in producing a decellularized tissue for immediate use as a TE scaffold, it 
would be preferable to retain the original hydration state of the tissue after treatment. 
 
5.4 Conclusions 
A novel method for treating hydrogels, tissues, and other hydrated biomaterials 
with presaturated scCO2 is presented.  The method eliminates or heavily reduces the 
extraction of water and other volatiles that has been observed during scCO2 treatment of 
biomaterials.  In the model biomaterial studies, it was determined that dry scCO2 extracts 
considerably more water from hydrogels and tissues than presaturated scCO2.  It was also 
determined that dry scCO2 treatment removes water from tissues more slowly than 
vacuum drying, but that the amount of water extracted by dry scCO2 is still enough to 
potentially alter the properties of a hydrated TE scaffold.  Even presaturated scCO2 does 
extract some volatile components from the tissue, though further analysis is required to 
verify this. 
From these observations, we conclude that presaturation of scCO2 can be used to 
prevent undesired dehydration of biomaterials for TE applications, allowing treated 
biomaterials to be used immediately instead of requiring a rehydration step.  Having 
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overcome this obstacle, further investigation into scCO2-based fabrication of tissue 
engineering scaffolds is warranted, including decellularization of natural tissues.  
Maintaining properties such as porosity and mechanical strength will be important as this 
technology is further developed.  
91 
Chapter 6 Decellularization of Porcine Aorta Using Supercritical CO2
6.1 Introduction 
 Over 8,000 Americans die annually while awaiting an organ transplant, and 
currently over 120,000 Americans are on the national waiting list.  Furthermore, the 
average wait time to obtain an organ transplant is several years [1].  One way to address 
this problem is by replacing damaged tissues and organs with ones created by tissue 
engineering (TE), which could greatly reduce transplant wait times and also alleviate the 
current dearth of available organ donors.  However, tissues and organs are extraordinarily 
nuanced and complicated structures, which creates numerous criteria for developing 
effective biomimetic materials. 
Whether derived from synthetic or natural materials, TE scaffolds must be sterile, 
porous, mechanically strong, biocompatible, and of appropriate stiffness and surface 
chemistry for the application at hand [2].  Additionally, scaffold fabrication can introduce 
numerous mechanical and biochemical deficiencies, including loss of mechanical 
strength, loss of surface activity, denaturation of extracellular matrix (ECM) proteins, 
scaffold dehydration, and residually cytotoxic solvents, detergents, and/or crosslinking 
agents [47].  All of these challenges require novel and innovative TE scaffold fabrication 
methods to be continually developed and refined. 
 Additionally, TE scaffolds must direct cell proliferation and differentiation during 
tissue growth.  This is a particular strength of naturally-derived biomaterials, which have 
recently been shown to promote constructive remodeling during tissue growth [7].  In 
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particular, scaffolds prepared from decellularized tissues are uniquely able to receive and 
transmit signals to cells, an interaction called dynamic reciprocity [125].  Acellular ECM 
scaffolds have also been shown to elicit an anti-inflammatory immune response, which 
may be related to a reduced risk of immune rejection [5]. 
 Decellularization is accomplished using a variety of different techniques, 
including physical [15], chemical [219], and enzymatic treatment [163].  Treatment with 
aqueous detergents, such as sodium dodecyl sulfate (SDS) and Triton X-100, is most 
common.  Detergents lyse cell and nuclear membranes, but also denature proteins, which 
often leads to thorough cell removal but can also disrupt glycosaminoglycans (GAGs), 
growth factors, and ECM ultrastructure [13].  Because of these hazards, it has become 
common for protocols to use detergents at very low concentrations over several days or 
even weeks, minimizing ECM damage while eventually removing all cells [17].  Though 
this approach is effective, novel methods are desired to decellularize tissues as effectively 
but with shorter treatment times and without using harsh chemicals or solvents for long 
periods. 
One relatively unexplored method worthy of consideration is treatment with 
supercritical carbon dioxide (scCO2).  scCO2 is non-toxic, non-flammable, and relatively 
inert.  Its mild critical temperature (31.1°C) makes it viable physiologic temperatures, 
and it has desirable transport properties such as high diffusivity, relatively high density, 
and low viscosity [21].  scCO2 has been used extensively in TE applications that involve 
synthetic materials, particularly in polymer foaming, where CO2 is used to fabricate TE 
scaffolds from synthetic polymers [27-29].  scCO2 has also been utilized in other 
biomedical applications, including extraction of biologically-relevant molecules [25, 26], 
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critical point drying [57], pasteurization [22-24], and sterilization of biomaterials and 
medical devices [30-37]. 
A novel decellularization technique using scCO2 offers considerably faster 
decellularization, on the order of hours instead of days.  The absence of harsh chemicals 
or solvents could also mitigate damage to the ECM.  In 2008, Sawada et al. used scCO2 
to decellularize porcine aorta, but dehydration of the scaffold during treatment prevented 
further progress [43].  In Chapter 5, we presented a method, presaturation of scCO2 with 
water, that greatly reduces tissue dehydration during scCO2 treatment [211].   
Our broad aim is to develop a novel scCO2 decellularization method that also 
maintains the hydration state of the treated tissue.  The objectives of this chapter are: (1) 
to examine the extent of decellularization in porcine aorta using scCO2 with different 
additives, pretreatments, and thermodynamic conditions; and (2) to present a hybrid 
detergent/scCO2 treatment that decellularizes the tissue more quickly and as effectively 
as a standard detergent treatment.  Achieving these objectives will enable further 
development of CO2-based decellularization and TE processes. 
 
6.2 Materials and Methods 
6.2.1 Tissue Procurement and Standard Detergent Treatment 
Porcine aorta was obtained from a local abattoir, rinsed with PBS and cut into 
ring-shaped sections measuring about 1 cm in length.  Specimens were stored at -20°C 
for up to 48 hr until being treated with scCO2 or a standard SDS treatment. 
The standard SDS treatment (treatment “S”; all treatments are listed in Table 6.1) 
was performed according to the protocol of Funamoto et al [171].  Tissues were  
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Table 6.1: List of Decellularization Treatments 
Treatment Name Treatment Description 
A 1 hr scCO2 with added water 
B 1 hr scCO2 with added water & Ls-54 
C 1 hr scCO2 with added ethanol 
D 1 hr scCO2 with added water & ethanol   
S 48 hr SDS/enzymes + 24 hr PBS wash (“standard treatment”) 
H 48 hr SDS/enzymes + 1 hr scCO2 “wash” (“hybrid treatment”) 
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pretreated for 1 hr in a solution containing 0.2% (w/v) EDTA and 10 mM pH 8 Tris 
buffer to increase cell membrane permeability.  They were then decellularized for  
48 hr under light agitation in 0.1% (v/v) SDS, 10 mM Tris buffer, 0.2 mg/mL DNase I, 
and 0.02 mg/mL RNase A.  Specimens were washed with PBS several times over the 
course of 24 hr to remove cell debris and residual detergent; thus the total time required 
for decellularization was 72 hours. 
 
6.2.2 Decellularization with Supercritical CO2 
The aorta specimen (8) was loaded into the treatment chamber (7) of the scCO2 
apparatus, shown in Figure 6.1.  The apparatus contained valves and fittings rated for 
high pressures up to 68.9 MPa (2).  Liquid carbon dioxide (1) was compressed in a 
chilled syringe pump (3) and slowly bubbled into the presaturation chamber (5) to 
maximize mass transfer.  In this chamber, the additive and scCO2 were stirred vigorously 
until reaching thermodynamic equilibrium (10-15 min with water and water solutions, 1-
2 min for pure ethanol).  Four different additive solutions were used to determine whether 
aqueous additives enhanced decellularization: (treatment “A") water, (“B”) water + 
Dehypon Ls-54 surfactant (BASF America, Florham Park, NJ), (“C”) ethanol, and (“D”) 
water + ethanol.  
Once equilibrium was reached, the valve to the treatment chamber was opened, 
and scCO2 flow was programmed to 1 mL/min at the pump inlet.  During treatment, the 
environmental chamber (4) was used to maintain the temperature at either 10 or 37°C, 
and a back-pressure regulator (11) was used to keep the pressure of the scCO2 in the 
vessels constant at either 10.3 or 27.6 MPa (1500 or 4000 psi, respectively).  A manual  
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Figure 6.1 – Supercritical CO2 Decellularization Schematic: 1 – CO2 Cylinder; 2 – High 
Pressure Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation 
Chamber; 6 – Stirring Bar & Additive Solution 7 – Treatment Chamber; 8 – Aorta 
Specimen; 9 – Pressure Gauge; 10 – Hand Pump; 11 – Back Pressure Regulator  
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hand pump (10) was used to depressurize the system at a rate of 0.34 MPa/min (50 
psi/min). 
 
6.2.3 Hematoxylin and Eosin (H&E) Staining 
 After treatment, tissues were fixed in 10% neutral buffered formalin for at least 24 
hr and embedded in paraffin.  Tissues were then cut into 5 μm sections using a microtome 
and deparaffinized by immersion in xylene (3 times), 100% ethanol, 95% ethanol, 80% 
ethanol, and finally water.  The tissues were stained with hematoxylin for 7 minutes, 
washed with water and ammonia, and then stained with eosin for 2 minutes before being 
dehydrated by immersion in 80% ethanol, 95% ethanol, 100% ethanol, and finally xylene 
(3 times).  A coverslip was mounted on slides, which were then viewed using a light 
microscope (Nikon E600, Tokyo, Japan) after waiting at least 24 hr for the slides to dry.   
 
6.2.4 DNA Quantitation 
 DNA was quantified using the DNAzol reagent kit (Invitrogen, Carlsbad, CA) 
according to the prescribed protocol with minor changes.  25 mg of dry aorta were flash-
frozen in liquid nitrogen and ground with a mortar and pestle.  Specimens were then 
placed in a 2 mL tissue homogenizer (VWR International, Radnor, PA) with 0.5 mL of 
DNAzol reagent and ground for 5-10 strokes or until fully dissolved.  The solution was 
then centrifuged at 10,000 x g for 10 minutes and the supernatant was recovered.  0.25 
mL of 100% ethanol was added to precipitate the DNA, which was recovered and washed 
twice with 70% ethanol for 1 min per wash.  DNA was air-dried for 5 sec and re-
dissolved in 4 mM sodium hydroxide (pH 9).  Optical density was measured at 260 nm 
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using a spectrophotometer (DU 730 model, Beckman-Coulter, Brea, CA) and the DNA 
concentration was calculated based on the absorbance measurement and initial mass of 
the tissue 
 
6.2.5 Basic Physical Characterization 
 Aorta specimens from treatments A, B, C, and D were weighed before and after 
scCO2 treatment using an analytical mass balance (Mettler Toledo, Columbus, OH) and 
compared to the mass of untreated samples and to each other.  Additionally, samples 
were photographed with a digital camera (PowerShot SX500, Canon Inc., Tokyo, Japan) 
and analyzed for changes in size, color, and overall appearance. 
 
6.2.6 Scanning Electron Microscopy (SEM) 
 After treatments C and D, samples were crosslinked with 2% glutaraldehyde (TCI 
America, Portland, OR) in 0.1 M sodium cacodylate buffer, pH 7.2 (Fisher Scientific, 
Hampton, NH), overnight at 4°C.  The sample was then washed 5 times in 0.1 M 
cacodylate buffer (pH 7.2) for 1-2 min each and then post-fixed in 1% osmium tetroxide 
(Fisher) for 1 hr at 4°C.  After secondary fixing, the specimen was washed 3 times in 
cacodylate buffer and then dehydrated in gradually increasing ethanol rinses (50%, 70%, 
80%, and 95%) for 10 min each and finally rinsed twice in 100% ethanol for 10 min per 
wash to fully dehydrate the specimen. 
 Specimens were then transferred into microporous vials, immersed in ethanol, and 
placed in a critical point dryer (CPD3 – Ladd Research Industries, Williston, VT).  
During critical point drying, the sample was submerged in liquid CO2 at 6.2 MPa (900 
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psi) at 10°C and the temperature was gradually increased to 40°C, reaching the 
supercritical CO2 state.  The pressure was then decreased to atmospheric at a rate of 0.69 
MPa/min (100 psi/min).  Dried specimens were mounted on a stub and coated with gold 
twice using a sputter coater (Denton Vacuum, Moorestown, NJ) and then loaded into the 
SEM.  The SEM used was the Vega3 SBU (Tescan, Brno, Czech Republic) and was used 
at a working voltage of 10 kV. 
 
6.2.7 Hybrid SDS/CO2 Treatment 
 After analyzing the results of the above treatments, development of a hybrid 
detergent/scCO2 treatment was desired.  The hybrid treatment (“H”) involved exposure of 
tissue to the standard detergent treatment solution described in section 6.2.1, followed by 
1 hr scCO2 treatment described in section 6.2.2 in lieu of the PBS wash.  Water and 
ethanol were used together as additives.   
 
6.2.8 Mechanical Testing 
 The mechanical properties of aorta specimens from treatments S, C, and H were 
examined using a uniaxial ring test as described by Twal et al. [220].  Annular samples 
were mounted onto a Bose Electroforce 3230 Biomechanical Tester (Bose Corp., 
Farmingham, MA) using two parallel cannulas.  Specimens were subjected to three 
preconditioning cycles at a rate of 0.05 mm/s with a maximum stretch ratio of 1.2 during 
each cycle.  Samples were kept moist with PBS during preconditioning to prevent 
dehydration.  At the start of the identical fourth cycle, load and displacement data were 
recorded at a rate of 50 points/sec using the accompanying Wintest software. 
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6.2.9 Residual SDS Quantitation 
 Residual SDS from the standard and hybrid treatments was quantified using an 
SDS Detection and Estimation Kit (G Biosciences, St. Louis, MO).  The assay involved 
mixing 1 mL methylene blue dye with 0.5 mL extraction buffer and 5 μL of aqueous 
solution containing SDS, then vortexing for 30 seconds.  1 mL of chloroform was then 
added, then the mixture was vortexed again for 30 seconds.  Methylene blue is extracted 
into the organic phase if SDS is present.  After waiting 5 minutes, the bottom chloroform 
phase was sampled and optical density was measured at 600 nm.  SDS concentration was 
calculated by comparison to a standard curve. 
  
6.2.10 Statistical Analysis 
Numerical data is presented as mean values plus or minus one standard deviation.  
A Student’s t-test was used to analyze confidence in statistical differences between 
groups.  95% confidence (p < 0.05, indicated by *) was considered to be statistically 
significant, while 99% confidence (p < 0.01, **) was considered highly significant. 
 
6.3 Results and Discussion 
The objective of decellularization is to maximize removal of cells and cellular 
debris while minimizing alteration done to the ECM during treatment [13].  A successful 
decellularization protocol utilizing scCO2 would quicken the process considerably and 
could do so using a benign solvent that leaves no residual material in the matrix. 
Currently, there is no universally-accepted standard for evaluating the extent of 
decellularization.  This is not surprising, because tissues vary greatly in stiffness, cell 
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density, ECM composition, and numerous other characteristics.  Therefore, 
decellularization processes must be tailored to the specific tissue of interest [122].  
However, Badylak’s group recently proposed a list of three criteria that can adequately 
describe a decellularized tissue of any kind.  They are [12]: 
1. Lack of visible nuclear material in H&E and/or DAPI-stained sections 
2. Total amount of double-stranded DNA less than 0.05 μg/mg dry tissue 
3. No individual DNA fragment longer than 200 base pairs 
In this study, we focused on the first two criteria by performing H&E staining and DNA 
quantitation on porcine aorta after scCO2 treatment. 
Six different treatments of porcine aorta were undertaken to determine the extent 
of decellularization.  They included two controls: SDS treatment and treatment with dry 
scCO2, and treatment with presaturated scCO2 using four different additive mixtures: 
water, water/Ls-54, ethanol, and water/ethanol.  The thermodynamic conditions chosen 
were based on the factorial design and process optimization performed in Sawada’s work 
[43]. 
 
6.3.1 Extent of Decellularization with scCO2 – Histology 
 Tissue sections from each treatment were stained with hematoxylin and eosin 
(H&E) and observed under an optical microscope.  Hematoxylin is a basic, positively 
charged stain that binds to the acidic, negatively charged nuclear envelope and chromatin, 
staining it black or purple.  Eosin is an acidic, negatively charged stain that binds to 
positively-charged ECM proteins like elastin and collagen.  There were three controls in 
this study: the untreated tissue as a negative control, and the SDS-treated tissue and dry  
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Figure 6.2 – Histology of Control Specimens: H&E stained sections of untreated (a), 
SDS-treated (b), and dry scCO2-treated (c) porcine aorta.  Scale bars represent 50 μm. 
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CO2-treated tissue as positive controls.   
Sections from the tunica media of each of the controls can be seen in Figure 6.2.  
In the native tissue (image a on the figure), the elastic fibers of the ECM are parallel with 
regular spacing between them.  Round or elliptical whole smooth muscle cells are 
attached to the elastic fibers.  The middle image on the figure (b) shows the same tissue 
after treatment with SDS and a PBS wash.  Few intact cells are visible, indicating some 
degree of disruption.  However, dark, irregularly-shaped areas of cellular debris are 
observed, indicating incomplete cell removal.  Additionally, significant damage to the 
ECM fibers is evident based on their widespread breakage and deformation.  Tissue 
treated with dry (pure) scCO2 (image c) primarily has intact, undisturbed cells like the 
native tissue, though a few cells appear to be shriveled or completely removed based on 
the empty space in the micrographs.  Elastic fibers are disturbed somewhat, as some 
shrinkage is observed and the spacing between fibers is less uniform, but unlike the SDS 
treatment, the fibers are not entirely broken. 
 These findings can be explained by considering the known mechanisms of how 
detergents and supercritical fluids interact with cells and proteins.  The SDS results 
mirror the literature; it is well-known that most ionic detergents, including SDS, can 
disrupt both the cell and nuclear membranes by replacing molecules in the lipid bilayer 
via the micelle effect [13].  This effect leads to intracellular contents exiting the confines 
of the cell and leaving the black, irregular areas of cellular debris found in the 
micrographs.  However, SDS alone does not remove the cellular debris from the matrix; 
debris is usually removed by prolonged washing with a saline solution.  In this work, 
washing with PBS was done for a relatively brief 24 hr according to Funamoto’s protocol   
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[171], but Simionescu’s group and others have shown that saline rinses often require 
several days or even weeks to remove all residual cellular material and detergent from a 
decellularized blood vessel [17].  It is also well-documented that SDS denatures proteins, 
so the shrinkage and cleavage of elastic fibers is not surprising. 
 Treatment with dry scCO2 was much less disruptive to elastic fibers in the ECM 
than SDS treatment.  Though no breakage was observed, there is still a clear loss of 
uniformity in both fiber size and spacing.  This is a reasonable outcome, given that tissue 
dehydration is a known effect of dry scCO2 treatment.  However, pure scCO2 was 
ineffective at removing cells from the matrix.  This outcome matches previous 
observations by Sawada’s group that scCO2 is ineffective at cell removal without an 
additive [43].  Though there is a currently a clear lack of experimental proof, it has been 
proposed that the mechanism of scCO2 decellularization is extraction of both whole cells 
and cellular debris [12].  Because these materials are charged, dissolution in pure scCO2 
is minimal because carbon dioxide is a nonpolar molecule.  This suggests using a polar, 
CO2-soluble additive to aid in decellularization, as described in the following. 
 Four different additives were used to presaturate scCO2 in an attempt to improve 
cell removal: water (A), water + Ls-54 (B), ethanol (C), and water + ethanol (D).  H&E 
sections from treatments A and B are shown in Figure 6.3 alongside the untreated tissue.  
With regard to decellularization, there appears to be no more removal than with dry 
scCO2 (Figure 6.2c).  This is not surprising, because although water is polar, it has 
relatively low solubility in scCO2 (less than 0.01 mole fraction at the conditions studied) 
[214], meaning that the humidified CO2 still is highly nonpolar and unlikely to extract 
polar components.  Using water as an additive does appear to improve the continuity and 
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Figure 6.3 – Histology of Water and Water/Ls-54 Additives: H&E stained sections of 
untreated (a), water/scCO2-treated (b), and water/Ls-54/scCO2-treated (c) porcine aorta.  
Scale bars represent 50 μm.  
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uniformity of elastic fibers, which makes sense since the tissue is not dehydrated by this 
treatment. 
Figure 6.3 also shows the effect of adding Ls-54 to the solution to be minimal.  
Ls-54 is a non-fluorinated surfactant that has been shown to have solubility in dense-
phase CO2 and water (about 0.001-0.005 mole fraction) and to be an effective additive for 
removing bacterial endotoxin from a solid surface [103, 104].  However, it appears to be 
ineffective in enhancing decellularization, probably because its chemistry differs from 
SDS despite them both being surfactants.  Though their alkyl chain lengths are similar, 
Ls-54 contains a hydroxyl group at the end of its chain rather than the highly dissociative 
sodium ion of SDS.  Ls-54 also contains several ethoxyl and propoxyl groups, whereas 
SDS has a long, nonfunctionalized alkyl chain.  These characteristics give SDS 
amphiphilic properties that interact with the lipid bilayer in cell membranes much more 
readily than Ls-54. 
The ineffectiveness of Ls-54 could also be related to treatment temperature.  Past 
work has shown an inverse proportionality between temperature and Ls-54 solubility in 
CO2, including into the liquid CO2 phase [105].  Treatment B was also conducted at 
10°C, where CO2 is more dense and exists in the liquid phase at the treatment pressure, 
but no significant changes in extent of decellularization were observed (Figure 6.4).  
While it is generally expected that thermodynamic conditions will affect the extent of 
decellularization, it is likely that this particular treatment is so far from achieving 
complete decellularization that these effects cannot be ascertained at this magnification. 
 To further increase the polarity of the scCO2 mixture, two final treatments were 
investigated, using ethanol and ethanol/water as additive solutions.  Figure 6.5 displays  
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Figure 6.4 – Effect of Thermodynamic Conditions on Extent of Decellularization: H&E 
stained sections with water/Ls-54 as the additive solution at the three different 
thermodynamic conditions: (a) low density (10.3 MPa, 37°C), (b) medium density (27.6 
MPa, 37°C), and (c) high density (27.6 MPa, 10°C).  No significant changes in extent of 
decellularization were observed between treatments.  Scale bars represent 50 μm. 
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Figure 6.5 - Histology of Ethanol and Ethanol/Water Additives – H&E stained sections of 
untreated (a), ethanol/scCO2-treated (b), and ethanol/water/scCO2-treated (c) porcine 
aorta. Scale bars represent 50 μm.   
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H&E-stained sections from these treatments.  Treatment with ethanol alone shows 
considerable shriveling and branching of the elastic fibers, as was expected.  However, 
the use of ethanol does not aid considerably in cell removal.  Though some of the areas 
where the ECM is damaged have fewer cells, the intact elastic fibers have numerous 
intact cells attached to them.  The addition of water to the ethanol does not markedly 
change the extent of decellularization, but does significantly improve the condition of the 
elastic fibers.  This finding is expected based on Figure 6.3 and the findings of Chapter 5; 
the primary objective of using water as an additive is to prevent dehydration, not to 
remove cells.   Overall, the three treatments that included water as an additive were 
notably more effective in maintaining the alignment of the elastic fibers than ethanol 
alone.  This supports findings in our previous work, which showed that presaturating 
scCO2 with water before treatment prevents dehydration of the ECM during scCO2 
treatment.   
On the contrary, when ethanol is the only additive, shriveling and fraying of the 
ECM fibers is observed, as in Sawada’s paper.  These findings were also confirmed 
visually and by manual handling, as treatment clearly increased the rigidity of the matrix 
when water was not added, while the addition of water maintained the apparent flexibility 
and pliability of the material.  Though interesting, the prevention of tissue dehydration is 
made impractical by the lack of cell removal in any of the experiments. 
The physical properties of treatments A, B, C, and D were analyzed by mass 
measurement, photography, and scanning electron microscopy (SEM).  These findings 
were rendered impractical by the lack of decellularization, but have been preserved in 
Appendix C for the sake of completeness. 
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6.3.2 Extent of Decellularization with scCO2 – DNA Quantitation 
Ultimately, microscopy indicates only very limited cell removal with the four 
scCO2 + additive treatments, and not nearly enough to indicate decellularization.  To 
confirm visual microscopy results, we employed quantitation of DNA as a measure of 
decellularization; one of the proposed criteria for establishing decellularization is a 
double-stranded DNA concentration below 0.05 μg DNA/mg dry tissue [12].  For each 
treatment in this study, DNA was extracted and its concentration was calculated based on 
spectrophotometric absorbance readings.  Results of DNA quantitation are shown in 
Figure 6.6.  All treatments show some amount of DNA removal compared to the 
untreated tissue.  However, no treatments aside from the standard SDS method approach 
the target maximum concentration of 0.05 μg DNA/mg dry tissue.  
The results of DNA quantitation follow the histological findings, where SDS was 
required in some capacity to rupture cell membranes and attain at least an appreciable 
amount of cell removal.  The four scCO2 additives do reduce the DNA content compared 
to the untreated tissue, though none of the treatments approach complete 
decellularization, as with the H&E findings.   
The failure of the scCO2/ethanol mixture to decellularize is the most surprising 
result, given that this finding is in direct opposition to the findings of Sawada’s group and 
that the experiments and the apparatuses used in both studies are both similar.  While 
there may be unknown differences in equipment or specimens that create a significant 
difference between the studies, our results lead us to question Sawada’s findings.  When 
analyzing the results of an experiment, particularly one where mechanistic steps cannot 
be viewed in situ, it is imperative to consider the underlying mechanisms to glean 
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Figure 6.6 - DNA Quantitation: Standard & scCO2 Treatments: Values below the red line 
(0.05 μg DNA/mg dry tissue) would indicate complete decellularization.  All treatments 
showed significant DNA removal compared to the control, but none neared adequate 
decellularization except for the SDS treatment. 
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information about what is physically occurring during the experiment. 
 The limited discussion in the literature on scCO2 interaction with cell membranes 
includes two possibilities: supercritical extraction of cells or cellular debris as a primary 
mechanism, and physical dislodging of cells from the ECM caused by high pressure.  
Based on our findings, we do not expect the high pressure alone to remove cells; other 
work has been published where blood vessels have been decellularized with high 
hydrostatic pressure – pressures on the order of several hundred MPa – and cells still 
require long-term continuous washing to be removed in these applications [171].  This 
suggests renewed focus on the extraction mechanism.   
 
6.3.3 SDS/scCO2 Hybrid Treatment for Decellularization 
Earlier in this chapter, the ineffectiveness of Ls-54 surfactant in decellularization 
was discussed, possibly because of its inability to permeate the cell membrane.  We 
theorized that scCO2 in general may suffer from this same problem.  To test this 
hypothesis, a two-step hybrid SDS/CO2 decellularization treatment was investigated.  
With this treatment, tissues were treated with SDS as described in section 6.2.1, but 
without the subsequent PBS wash.  Instead, tissues were then treated (washed) for 1 hr 
with scCO2 presaturated with ethanol and water at the same thermodynamic conditions 
used previously.  
 The effect of the hybrid treatment can be seen in Figure 6.7.  Using this hybrid 
approach, there are no visible intact cells or cellular debris.  Therefore, it is likely that the 
tissue is fully decellularized.  This is an exciting and intriguing result that suggests polar   
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Figure 6.7 – Histology of Hybrid Treatment: H&E stained sections of untreated (a), SDS-
treated (b), and SDS/scCO2-treated (c) porcine aorta.  Image (c) shows complete 
decellularization.  Scale bars represent 50 μm. 
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supercritical CO2 will extract intracellular debris, but cannot do so unless another agent is 
used to enhance membrane permeation or rupture.  Significantly, the ECM fibers appear 
to be intact and mostly undisturbed compared to the complete SDS treatment. 
Maintenance of fiber integrity may be a result of shorter exposure time to SDS; the 
scCO2/water + ethanol “wash” takes only an hour instead of the day or more required for 
PBS washing.   
DNA quantitation from the hybrid method, along with the results of the other 
treatments, can be seen in Figure 6.8.  The figure shows a level of DNA removal similar 
to the standard SDS treatment, below the threshold for decellularization with a 
concentration of 0.036 μg DNA/mg dry tissue.  This is a very exciting result, as the  
hybrid method is able to achieve the original objective: to decellularize effectively while 
avoiding dehydration of the tissue. 
It should be noted that the DNA test performed has sensitivity limitations with the 
spectrophotometer used.  Optical density near the decellularization threshold is very low, 
approaching the tolerance of the instrument.  Thus, some error may be present in the 
numerical value of the DNA concentration for SDS-containing treatments.  However, the 
histological results and statistical comparison to the other treatments confirm the efficacy 
of the method. 
To analyze the physical properties of treated aorta, uniaxial tensile testing was 
performed on samples from selected scCO2 treatments (S, C, and H).  Stress responses 
for each treatment are plotted against stretch ratio on Figure 6.9.  The bimodal stress 
response seen for each treatment in the figure is normally observed when blood vessel 
tissue is subjected to a uniaxial ring test [220, 221].  The first linear segment, observed 
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Figure 6.8 – DNA Quantitation including Hybrid Treatment: Bar chart displaying the 
DNA content of each detergent and scCO2 additive treatment.  Values below the red line 
(0.05 μg/mg) indicate adequate decellularization according to Crapo’s standard. 
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Figure 6.9 – Uniaxial Ring Test of Treated Aortas: Compared to native aortas (blue), C 
treatments (scCO2 plus ethanol, purple) have a sharper stress response while the response 
after standard SDS treatments (red) have a flatter slope.  The SDS/scCO2 hybrid 
treatments (green) are most similar to the untreated aorta.  
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for stretch ratios from about 1.0-1.08, is primarily governed by elastin.  The response of 
the second linear segment, observed for stretch ratios from 1.12-1.2, is governed by 
collagen.  Contributions to modulus of elasticity by both collagen and elastin were 
calculated for each treatment and are listed on Table 6.2.  As expected, SDS exposure 
denatures proteins and reduces stiffness, while treatment with scCO2 and ethanol causes a 
significant increase in stiffness because of dehydration.  Both of these extremes are 
mitigated by the hybrid treatment: faster treatment reduces protein denaturation and 
presaturation with water prevents matrix dehydration.  However, the hybrid treatment 
does cause a significant decrease in MOEelastin, though the decrease is less dramatic than 
that caused by the standard SDS treatment. 
 It should be noted that the uniaxial ring test has some limitations.  First, a uniaxial 
test does not accurately represent the stresses applied to blood vessels in vivo, as those  
stresses are biaxial and vary with time and blood pressure.  Additionally, blood vessels 
are highly anisotropic, so using globalized values of stretch ratio and strain can introduce 
error for specific locations on the specimen, especially those near the clamps on each end.  
A more robust approach would include biaxial testing with monitoring of local stresses 
and strains using a digital camera or other imaging device, as others have demonstrated. 
[222, 223]. 
 Removal of SDS is another consideration for scaffold viability, as cytotoxicity is 
observed for many cell types at concentrations greater than about 0.002% SDS [164].  
Residual SDS was quantified for the standard SDS treatment and the SDS/scCO2 hybrid 
treatment, Figure 6.10.  The figure shows that one hour of scCO2 treatment removes 
about as much SDS as 24 hours of washing with PBS, a significant time savings.  PBS  
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Table 6.2 – Elastic Moduli for Uniaxial Ring Tests 
Treatment MOEElastin (kPa) MOECollagen (kPa) 
Untreated 350.8 ± 18.8 717.1 ± 49.3 
SDS w/ PBS Wash (S) 106.2 ± 24.2** 306.0 ± 23.5** 
scCO2 + ethanol (C) 715.0 ± 61.9** 988.3 ± 50.6** 
SDS/scCO2 Hybrid (H) 232.4 ± 59.5* 743.4 ± 49.5 
 
*p < 0.05 compared to native aorta 
**p < 0.01 compared to native aorta 
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Figure 6.10 – SDS Quantitation Assay: SDS was quantified before and after washing 
with either PBS or scCO2.  1 hour of scCO2 treatment compares similarly to 24 hours of 
PBS washing, though neither reduces SDS concentration below the cytotoxic level of 
0.002%.   
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washes also have diminishing returns, making the wash step last several days in many 
protocols to reduce SDS below cytotoxic levels [224].  Thus, scCO2 could compare even 
more favorably over longer time periods.  This finding also indicates some solubility of 
SDS in the scCO2 treatment solution; solubility may be low because SDS a charged 
molecule, but SDS does have similar molecular weight to other molecules extracted by 
scCO2 in this dissertation, such as glutaraldehyde and Ls-54. 
 
6.4 Conclusions 
A novel scCO2 method for decellularizing porcine aorta without compromising its 
hydration state.  This method offers considerably faster decellularization of tissues 
without requiring long-term exposure to detergents or organic solvents.  As anticipated, 
nonpolar scCO2 solutions were proven ineffective for decellularizing porcine aorta by 
both histology and DNA quantitation, though presaturating scCO2 with water did better 
maintain the hydration state of the matrix, even in the presence of other additives.  More 
surprisingly, the addition of ethanol to increase scCO2 polarity did not substantially 
intensify the extent of decellularization, suggesting that scCO2 alone is unable to lyse the 
cell membrane and that the previously proposed mechanism of whole-cell extraction is 
unlikely to be valid. 
The inability of scCO2 alone is unable to disrupt cell membranes was further 
tested by the development of a hybrid decellularization protocol that utilized an SDS 
pretreatment step before washing with scCO2 and water plus ethanol as additives.  This 
treatment shows that scCO2 can extract intracellular material if the cell membrane is 
lysed beforehand.  Complete decellularization was achieved using this method, which 
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was about 24 hr faster than the standard method and maintained the hydration state of the 
native tissue.  Mechanical response of ECM decellularized by the hybrid treatment was 
similar to that of the native tissue, and most residual SDS was removed.  Still, further 
study is required to determine the capabilities and limitations of this method and to fully 
assess the effects of decellularization on the mechanical and biochemical properties of the 
matrix. 
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Chapter 7 Final Conclusions and Future Perspectives
Natural biomaterials present several advantages as TE scaffold materials.  
However, fabricating safe and effective biomimetic scaffolds challenging, and novel 
methods continue to seek improvements in functionality, safety, and fabrication 
efficiency.  Though scCO2 is commonplace in synthetic TE, its use in the fabrication of 
naturally-derived TE scaffolds, including collagen and decellularized ECM, is still in its 
infancy.  More research and development is required before the technologies presented in 
this dissertation become clinically viable or can be directly used for other practical 
applications.  In this brief chapter, some recommended avenues of future research are 
discussed. 
In Chapter 3, biochemical compatibility was demonstrated between type I 
collagen and scCO2 on both a chemical and physical level.  This discovery is a gateway 
for numerous practical applications going forward.  For example, in Chapter 4, scCO2 
was used as a crosslinking aid to remove residual glutaraldehyde from collagen films, 
avoiding the undesirable long treatment times and high temperature exposure normally 
required to remove unreacted glutaraldehyde.  Future research should include assessment 
of bioactivity, removal of other crosslinking agents, treatment of other types of collagen 
(type II, type III, etc.), and also to three-dimensional collagen constructs, as the 
morphologies explored in this dissertation, collagen fibers and films, are relatively 
simplistic.  Many other applications are possible beyond crosslinking, such as scaffold 
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fabrication and sterilization with scCO2; some preliminary research exists on the latter 
[96, 225]. 
scCO2 was also explored as a novel decellularization agent.  Though previously-
reported tissue dehydration was prevented using a novel presaturation method presented  
in Chapter 5, studies in Chapter 6 showed that scCO2 alone is ineffective for 
decellularization.  Based on evidence that scCO2 is unable to penetrate the cell 
membrane, a hybrid treatment was designed using SDS to first lyse cell membranes 
followed by scCO2 extraction of intracellular debris.  Complete decellularization of 
porcine aorta was achieved with the hybrid method.  Furthermore, the hybrid method was 
faster than the standard method and did not compromise mechanical properties or deposit 
large amounts of residual SDS.   
These results are exciting, but much more study is still needed.  The logical next 
step for this work is a factorial design on the parameters of the hybrid method (e.g. SDS 
concentration and treatment time, scCO2 pressure, treatment time, and depressurization 
rate).  This would elucidate which parameters are critical for successful decellularization 
and allow the process to be optimized for faster treatment or tuning of specific scaffold 
properties.  Moving forward, it is imperative to verify scaffold bioactivity after scCO2 
treatment.  Bioactivity can be studied with an in vitro cell assay, such as Alamar blue or 
MTT.  More scaffold characterization should also be performed, including more robust 
biaxial mechanical testing and electron microscopy, which can determine the effect of 
scCO2 decellularization on surface properties and elastic fiber alignment.  Finally, 
recellularization and in vivo study using an animal model is required to determine the 
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efficacy of this decellularization method for clinical TE use.  Once the hybrid method is 
better understood, this technology can be extended to tissues other than blood vessels. 
Additionally, scCO2 should be investigated further regarding ECM sterilization.  
Xenogeneic scaffolds were recently classified as medical devices by the US Food and 
Drug Administration and therefore require terminal sterilization prior to clinical use 
[106].  Research on the effects of sterilization methods on ECM scaffolds has only 
recently begun [226], but scCO2 sterilization has been proven effective in this application 
and may offer several advantages over other methods [13, 30, 38, 39].  The ultimate prize 
for this research is an effective scCO2-based decellularization process that simultaneously 
sterilizes; such a process would greatly improve scaffold fabrication efficiency by 
eliminating an entire processing step.
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Appendix A: Supplemental DSC Data 
 
Figure A.1 – DSC Thermogram for 25°C Liquid CO2 Treatment: This response is much 
more similar to collagen after scCO2 treatment, indicating the effect of treatment 
temperature on collagen denaturation when treated with liquid CO2.  Noise in the 
thermogram resulted from the baseline scan.  
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Appendix B: Additional Circular Dichroism Data
 
Figure B.1 – CD Spectra of Native and Treated Collagen, 10 μg/mL: Positive peak 
observed at 225 nm and negative peak at 205 nm.  As the concentration increases, the 
magnitude of each peak does as well. 
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Figure B.2 – CD Spectra of Native and Treated Collagen, 20 μg/mL: No peaks are 
observed because the protein is completely unfolded and no longer has secondary 
structure. 
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Appendix C: Characterization of scCO2 -Treated Aortas
 Photographs and mass measurements were taken to analyze gross changes in 
appearance or weight caused by detergent and/or scCO2 treatment.  Photographs of aorta 
specimens after each treatment can be viewed in Figure C.1.  One can see obvious 
evidence of discoloration when dry CO2 (b) or CO2/ethanol (d) is used, which is likely a 
direct result of tissue dehydration.  When water presaturation is employed (c, e, and f), 
the color change is much less pronounced.    
 Changes in mass can are listed in Table C.1.  These results complement the 
photography and histology as well, with water presaturation treatments maintaining most 
of the mass (88-95%) while ethanol alone and dry scCO2 (to a much lesser extent) 
dehydrate the tissue.  These findings make sense based on our past work on presaturation 
and tissue dehydration: one would expect water-presaturated scCO2 to not disturb water 
in the tissues, dry scCO2 to extract to some water based on the solubility of water in 
scCO2, and an ethanol-scCO2 mixture to extract the most water because of the increased 
polarity compared to dry scCO2.   
 Scanning electron microscopy (SEM) was performed to determine if scCO2 
treatment disrupted the endothelium or three-dimensional ECM ultrastructure.  SEM was 
performed for untreated aorta and for treatments A and C.  Micrographs of the 
endothelial surface can be viewed in Figure C.2.  It is clear that treatment C, with ethanol 
alone as the additive, is more disruptive to the aorta surface, and that adding water 
prevents some of the damage.   
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Figure C.1 – Visual Appearance of Aorta Samples: (a) Untreated, (b) Dry CO2 treatment, 
(c) Water/scCO2 treatment, (d) Ethanol/scCO2 treatment, (e) Water/Ethanol/scCO2 
treatment, (f) Water/Ls-54/scCO2 treatment  
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Table C.1 – Changes in Tissue Mass During scCO2 Decellularization 
Treatment Starting Mass (mg) Final Mass (mg) % Mass Retained 
Dry CO2 372.4 271.0 72.8 
A (CO2 + Water) 250.1 238.7 95.4 
B (CO2/H2O/Ls-54) 284.6 245.1 86.1 
C (CO2 + EtOH) 273.7 84.4 30.9 
D (CO2/H2O/EtOH) 245.6 216.7 88.2 
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Figure C.2 – Endothelium SEM: SEM micrographs of the endothelium for (a) untreated 
aorta, (b) CO2/ethanol-treated aorta, and (c) CO2/ethanol/water-treated aorta. 
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 A look at the cross-sections of ethanol-treated and water/ethanol-treated aorta is 
shown in Figure C.3.  Here, it is clear that ethanol treatment disrupts the elastic fibers 
much more than when water is employed as an additive; Figure C.3a shows a tangled 
mass of different size fibers, while Figure C.3b shows a much more uniform fiber  
structure, both in terms of size and alignment; the latter is much more like the cross-
section of the native aorta [227].  This confirms histological observations (Figures 6.3 
and 6.5) that preventing dehydration by using water as an additive also helps preserve 
matrix ultrastructure.   
 It is should also be noted that it is inappropriate to look for cells in this 
circumstance because of the much larger magnification used in electron microscopy 
compared to light microscopy.  SEM is primarily concerned with surface structure and 
physical properties.  Additionally, the value of SEM is limited in this study because 
biological samples must be dehydrated before viewing for the method to work properly. 
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Figure C.3 – Cross-sectional SEM: SEM micrographs of the endothelium for (a) 
CO2/ethanol-treated aorta, and b CO2/ethanol/water-treated aorta. 
